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Skeletal muscle metabolism in exercise and recovery in chronic renal
failure. C. Thompson*, G. Kemp, D. Taylor, P. Barnes, P. Styles, C.
Winearls, B. Rajagopalan, G. Radda, MRC NMR Unit, John Radcliffe
Hospital, Headley Way, Oxford, 0X3 9DU, United Kingdom. Patients with
advanced kidney failure complain of early fatiguability that may be related
to anaemia or hyperphosphataemia. The extracellular concentration of
inorganic phosphate ([Pi]0) influences intracellular [Pi] ([Pi]j and [Pi]1
may modify ATP production by altering the phosphorylation potential(P.P. = [ATP}/{[ADP] X [Pi]}) or otherwise influencing mitochondrial
function. Using 31P magnetic resonance spectroscopy, we studied skeletal
muscle to determine the effects of elevated [Pi]0 on intracellular bioener-
getics. 18 non-dialysed patients with chronic renal impairment were
studied. The calf muscle was positioned over a surface coil within a
superconducting whole body magnet. Spectra were collected at rest,
during incremental plantar flexion and recovery, allowing calculation of
intracellular pH and [Pi], [phosphocreatine] (PCr), [ATP], [ADP] and the
maximum rate of mitochondrial ATP synthesis (Qmax). Results were
compared with age-matched control subjects. Omax is known to be a
sensitive indicator of mitochondrial dysfunction. [Pi], was increased in the
patient group (Pi/ATP = 0.49cf 0.38 in controls) and the [Pi]1 increase was
correlated with the [Pij0 (P < 0.01). In all patients, [ADP} adapted to the
increase in [Pi]1 and hence the P.P. remained constant throughout range of
[Pu1. The constant P.P. suggests no change in the control for oxidative
phosphoiylation in these uraemic patients. Since metabolism in skeletal
muscle at rest is purely aerobic, the constancy of the PP. implies that PP.
is more important than either [ADP] or [Pi]1 in the control of oxidative
phosphorylation. Qmax remained constant (35 mM/mm) throughout a
range of [Pi],, plasma [creatinine] and [Hb] and was similar to controls (32
mM/mm). Constancy of PP. and Omax over a similar range of [Pi], was
seen in dialysed patients but, unlike undialysed patients, there were
reductions in Omax and P.P. compared to controls. This suggests that
control of ATP synthesis was not affected by changes in [Pij1 and that the
institution of dialysis caused metabolic abnormalities in muscle nonexist-
ent in the presence of advanced renal failure prior to dialysis.
Long-term follow-up of patients with IgA nephropathy: The leading
cause of glomerulonephritis in New Zealand. R.R. Bailey*, KL. Lynn, R.A.
Robson, A.H. Smith, J.E. Wells, Department of Nephrology, Christchurch
Hospital, Christchurch. IgA nephropathy is the commonest form of
primary glomerulonephritis in the world. We report the outcome of 151
patients with biopsy-proven IgA nephropathy followed for up to 20 yr. On
30.4.73 the first patient with IgA nephropathy was diagnosed in this
department. From then until 21.8.92 a total of 151 patients have had this
diagnosis made. Of these, 120 were male giving a male:female ratio of
3.9:1. The age range was 6—74 yr, mean age 32.5, median age 29.6 (SD 15.4)
yr. All except 5 were Caucasian. Ninety-five (63%) patients presented with
microscopic haematuria, with or without proteinuria and/or renal insuffi-
ciency. At presentation renal insufficiency (plasma creatinine  0.12
mmol/L) was present in 34% and hypertension in 48%. During a mean
follow-up period of 63.3 mth (range 0—233 mth) 12 patients have reached
end-stage renal failure, 5 have died of a non-renal cause and 25 were lost
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to follow-up. The actuarial renal survival rate was 92.6% at 5 yr and 91%
at both 10 and 15 yr. A significantly poorer prognosis was seen in patients
with renal insufficiency, hypertension, 24 hour albumin excretion of 1 g,
or a serum albumin of <35 g/L at presentation, and this became apparent
within the first few years of follow-up. IgA nephropathy has a better
outcome than earlier thought. These findings should prove of value in
giving an individual patient a fairly precise prognosis at presentation.
Protein restriction in renal disease: Compliance and consequences.
C.A. Pollock*, L.S. Ibels, R.J. Caterson, D.A. Waugh, IF. Mahony, Depart-
ment of Renal Medicine, Royal North Shore Hospital, St. Leonards, NSW,
2065. Although restriction of dietary protein intake (DPI) is regarded as
useful in retarding the progression of renal disease, recent evidence
suggests this effect may not be as significant as originally supposed and
may result in poor nutritional reserve when end stage renal failure is
reached. 680 patients (aged 7—88 years) underwent 24 hour urine collec-
tions and the DPI was assessed from urea kinetic modelling. 526 patients
had a normal serum creatinine, and of these 360 patients had no dietary
restrictions. 166 patients were advised to follow a low DPI. 154 patients
had increased serum creatinine of which 105 patients had received advice
regarding restricted DPI. 7 patients were assessed before and after
commencement of dialysis. Patients with a normal serum creatinine who
had no dietary restriction had a significantly higher DPI than those advised
in protein restriction (0.79 0.1 vs. 0.72 0.1 g/kg/day (mean sEM); P
< 0.0001). However, in patients with abnormal renal function, dietary
protein intake was similar irrespective of dietary advice (0.73 0.03 vs.
0.69 0.02 g/kg/day; P = 0.28). A lower DPI correlated with renal
dysfunction independent of dietary advice (P < 0.0001). In the overall
population a low DPI was associated with a lower BMI (24.5 0.3 vs. 25.5
0.2; P < 0.005), a lower serum albumin (43.8 0.2 vs. 44.7 0.2; P <
0.005), and inverse correlations were observed between DPI and age (P <
0.0001), blood glucose (P < 0.002), serum cholesterol (P < 0.002) and
triglycerides (P < 0.0001). However, a disproportionate adverse effect on
blood glucose and lipids, and serum albumin were not observed in the
population with impaired renal function. Patients who reached end stage
renal failure had no significant alteration in DPI within a month of
commencement of dialysis (P = 0.86). The results of the study show that
the DPI of the community is lower than expected, but compliance with
dietary advice is evident. A low DPI in renal impairment occurs indepen-
dently of dietary advice. Despite evidence that a proportionately higher
carbohydrate intake may have adverse effects on the overall nutritional
profile, this is not more common in patients with impaired renal function.
Adaptation to a high protein diet following instigation of dialysis is
unsuccessful in the short term.
Cardiovascular risk factors are present in children and young adults
with renal disease. L.M Johnstone*J, CL. Jones', L.E. Grigg2, T. Billing-
ton3, J.L. Wilkinson4, R.G. Walker"5, HR. Powell', Departments of Nephrol-
ogy', Cardiology", Royal Children's Hospital, Parkville Vic., 3052, Depart-
ments of Nephrology3 and Cardiology2, Royal Melbourne Hospital, Parkville,
Vic., 3050, Department of Chemical Pathology5, St. Vincents Hospital,
Fitzroy, Vie., 3065. Cardiovascular disease is a major cause of morbidity
and mortality in adults with renal disease. Children with end stage renal
failure are now being treated successfully with renal replacement thera-
pies, and with long term survival may also be at increased risk of
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cardiovascular disease. To evaluate the prevalence of abnormalities in risk
factors for cardiovascular disease a cross-sectional study was undertaken
in a group of children and young adults with renal impairment or receiving
renal replacement therapy. One hundred and thirty-three subjects were
enrolled (60 controls, 33 patients with renal impairment (CRF), 10
patients requiring peritoneal dialysis (CAPD) and 30 patients post renal
transplantation (TX). Parameters studied included echocardiograph with
calculation of left ventricular mass (LVM) and serum lipid (total choles-
terol, triglyceride, VLDL-, LDL- and HDL-cholesterols) and lipoprotein
(apolipoproteins Al and B, lipoprotein (a)) concentrations. Serum cho-
lesterol was increased in all groups with renal disease, (controls: 4.6
mmol/l (2.9—7.6), CRF: 5.3 mmol/l (3.2_9.l)**, CAPD: 6.1 mmolIl (3.4—
8.2)**, TX: 5.2 mmolll (3.l_8.1)**); as was VLDL-cholesterol (controls:
0.5 mmol/l (0.2—1.3), CRF: 0.9 mmol/l (0.3...2.0)***, CAPD: 1.2 mmol/l
(0.416)***, TX: 0.7 mmol/l (0.0_1.5)**). LDL-cholesterol was increased
in CRF and TX subjects (controls: 2.6 mmol/l (1.3—5.5), CRF: 3.3 mmol/l
(1.l_.6.6)***, TX: 3.1 mmol/l (1.5_4.8)**). HDL cholesterol was de-
creased in the CRF and CAPD groups (controls: 1.44 mmolll (1.0—3.1),
CRF: 1.26 mmol/l (0.44_2.42)**, CAPD: 1.07 mmol/l (0.62l.28)***).
LVM was indexed for height and found to be significantly increased in
CAPD subjects (controls: 51.8 g/m (23.1—119.8), CAPD: 80.2 g/m (44.5—
100.9)*) and in TX subjects compared to age and sex matched controls
(controls 70.2 g/m (25.9—119.8), TX: 97.8 g/m (51.2_182.l)**). These
results showed that children and young adults with renal disease have
abnormal serum lipids with an atherogenic profile, and have an increased
LVM when receiving renal replacement therapy. Thus, children with renal
disease would appear to be at greater risk for premature cardiovascular
disease. Results expressed as median (range). * P < 0.05, 'P < 0.01,
***p < 0.001.
Comparison of simultaneous renal clearances of true endogenous
creatinine and subcutaneously administered iothalamate in man. Carol
Pollock*, A.Z. Gyoiy, Therese Hawkins, Margaret Ross and Lloyd Ibels,
Departments of Medicine, Sydney University and Renal Medicine, Royal
North Shore Hospital, St. Leonards, Australia 2065. Accurate measurement
of GFR in clinical practice is still problematic. Endogenous creatinine
clearance is the logical method but has suffered from poor reproducibility
and accuracy. In 71 (38 females) patients with various renal diseases we
compared simultaneously measured '25lothalamate (lOT) and true endo-
genous creatinine clearances (TCrC1) over two short collections periods of
1 and 2 hrs. True endogenous creatinine was measured by the Jaffe
adsorption method. Range of lOT was 5—141 mI/mm. Reproducibility of
the JOT method was 18.5% and that of the TCrCI 12.2% as obtained from
the two collection periods. Fig. 1 shows the correlation for the whole
group, while Fig. 2 for those with lOT less than 30 mI/mm. The slope of
the regression was not significantly different from 1 (95% confidence
interval (ci) = 0.964—1.155) for the whole group, nor in any subgroup
chosen. The intercept at 12.6 mI/mm (ci = 5.0—20.2) indicates that there
is some creatinine secretion, but that this a constant percentage of TCrCI
(unit slope). The probable reason why clearance of creatinine, using
methods other than those giving true creatinine values give such widely
vatying results, is because of variable contribution of other chromogens,
and because both serum and urine creatinine change significantly with
time if not refrigerated (long collection periods). It is concluded that
TCrCI obtained during short collection periods is an excellent, reproduc-
ible, accurate and convenient measure of GFR.
Subureteric Polytef injection in the management of vesicoureteric
reflux in children. PA. Dewan, D. W. Goh*, Urology Unit, Women's &
Children's Hospital, Adelaide, SA 5006. Subureteric Polytef injection is one
of the alternatives now available for the management of vesicoureteric
reflux in children. The results of the treatment by one surgeon, over a two
year period, were studied prospectively in 47 children (60 refluxing units).
Following a single injection, reflux was abolished in 49 (82%) ureters and
of the 11 failures, 10 ureters showed a reduction of the grade of reflux
while one remained unchanged. A repeat injection was performed in nine
of these ureters with success in five, persistence in two, and two children
are awaiting a follow-up cystogram. The conservative success, with the
addition of a second injection, was 90% (54/60). Of the four with
unresolved refiux, two have low grade reflux and are free of infection, and
two have had a ureteric reimplant, one of which was after a single
injection, at the request of the parents. There were no instances of ureteric
obstruction. These results show a viable, minimally invasive alternative to
open ureteric reimplantation in the management of vesicoureteric reflux
in children.
Oral trimethoprinl-sulphamethoxazole (TM-SMX) vs. inhaled pent-
amidine (P) for prevention of pneumocystis pneumonia (PCP) after renal
transplantation. E. Pedagogos*, K Nicholls, J. Wilson, K Walker, G.
Becker, Depts. Nephrology and Respirato,y Medicine, RMH. 61 patients
were randomised to receive prophaxis against PCP with either TM-SMX
800/160 mg B.D. (N = 32) or inhalational P 150 mg once a fortnight,
commencing 14-days after transplantation and continuing for 6 months.
All patients were treated with triple immunosuppression (prednisolone,
azathioprine (AZA) and cyclosporin A). 49 patients (26TM-SMX, 23P)
completed the study. No cases of PCP were seen. 5 patients died
(3TM-SMX, 2P) of non-respiratory causes, 2 further patients (1 in each
group) underwent graft nephrectomy for rejection, and 6 patients (2TM-
SMX, 4P) were withdrawn. Data was analysed according to intention to
treat. The dose of TM-SMX was halved if the serum creatinine level
increased >02 mmol/L (N = 12). Both treatment modalities were well
tolerated. Cough was common with P, but was controlled by slowing the
rate of the inhalation. Renal and respiratory function tests done before
treatment, and at 6 months, were not different in the 2 patient groups.
White cell counts (WCCs) were not significantly different between groups
at any time, but the tolerated AZA doses (decreased from 2 mg/kg/day if
WCC <4000/dL) were significantly lower in the P group (median daily
doses at 1 month 125 mg TM-SMX, 100 mg P NS: 3 months 141 mg
TM-SMX, 75 mg P < 0.05; 6 months 117 mg TM-SMX, 61 mg P < 0.05.
This suggests that P may aggravate bone marrow depression due to AZA
(Mann-Whitney U). Our patient numbers are too small to exclude small
difference in efficacy between the 2 treatments. We conclude that either
TM-SMX or P provides a well-tolerated option for PCP prevention, that
the required dose of TM-SMX is probably only 400/80 mg B.D. and that
TM-SMX is at least as good as that of P.
Deoxyspergualin inhibits local macrophage proliferation in rat renal
allograft rejection. P.G. Ken*, D.J. Nikolic-Paterson, KY. Lan, S. Rainone,
G. Tesch, and R. C. Atkins, Dept. of Nephrology, Monash Medical Centre,
Clayton Vic. 3168 Australia. Deoxyspergualin (DSP) is a potent immuno-
suppressive drug which can prevent allograft rejection. Although there is
good evidence that DSP can inhibit T and B lymphocyte responses, the
effect of the drug upon monocyte function is controversial. In the current
study, substantial local proliferation of inflammatory macrophages within
acutely rejecting rat renal allografts (41.6 5.5% of ED1+ cells on day 5
posttransplantation) was identified by expression of the proliferating cell
nuclear antigen (PCNA). This observation was confirmed by bromo-
deoxyuridine incorporation into macrophages within the tissue. Treatment
of animals with deoxyspergualin not only suppressed the degree of
mononuclear cell infiltrate, but it also significantly inhibited local prolif-
eration of macrophages within the graft (26.4 5.6% of ED1 + cells,P <
0.05 vs. untreated). This appeared to be, at least in part, a direct effect of
DSP upon macrophages since the drug also inhibited growth of two
monocytic cell lines (RC-2A, U937) in vitro. However, DSP treatment had
no effect upon lipopolysaccharide-induced monocyte JL-l/3, TNFa, and
IL-6 mRNA and protein production indicating that this drug is not a
general inhibitor of monocytes. In conclusion, this study has demonstrated
that local proliferation of macrophages within the kidney is a prominent
feature of acute allograft rejection and that inhibition of this response is
one mechanism whereby DSP exerts its potent immunosuppressive ac-
tions.
Prevalence of human T-cell leukemia virus type 1 (ffI'LV-l) antibodies





Kirubakaran * and L. Mollison, Department of Medicine, Alice Springs
Hospita4 Alice Springs, NT—0870. Infection with HTLV-1 is common
among Aborigines in Central Australia with reported prevalence rates up
to 14%. Dialysis centres in endemic areas of Japan have noted higher
prevalence (up to 19.7%) in haemodialysis patients, when compared to
healthy blood donors (4.3%). The higher prevalence was unexplained by
blood transfusions, but was suggestive of an association between HTLV-1
and chronic renal disease itself. The Central Australian Aborigines have a
high incidence of chronic renal failure with unknown aetiology and we
examined the sera of patients undergoing haemodialysis for HTLV-1
antibodies, in order to determine its prevalence and its possible associa-
tion with the underlying renal disease. All patients undergoing haemodi-
alysis at the dialysis unit in Alice Springs had their serum examined for
HTLV-1 antibodies after informed consent. The antibodies were detected
by a particle agglutination assay and positive results were confirmed with
a Western blot at a reference laboratory. Of the 31 Aboriginal patients, 13
(42%) were positive for HTLV-1 antibodies. Their ages ranged from
31—67 years (mean 44.6) and 10 (77%) were males. As a group, the
HTLV-1 positive patients did not differ significantly in terms of length of
time on dialysis, blood transfusions, age distribution and geographical
origin from the HTLV-1 negative patients. However, males were affected
more often and all 6 Hepatitis B carriers in the Unit were positive for
HTLV-1 also. The aetiology of renal failure was uncertain in 7 out of the
13 (54%) HTLV-1 positive patients, diabetic nephropathy in 2, obstructive
uropathy in 2, amyloidosis in 1 and IgA nephropathy in 1. The 6 patients
with Hepatitis B antigenemia shared two dialysis machines, but the other
7 did not show any association with the machines used for their haemo-
dialysis. As the antibody status prior to dialysis is unknown in these
patients, it is difficult to exclude cross infection as the cause of high
prevalence of HTLV-1 among them, but the present data does not support
this hypothesis. The strong association with renal failure of uncertain
aetiology suggests that HTLV-1 may be related in some way to the renal
disease in these patients. In view of the high incidence and possible
aetiological association, routine screening for HTLV-1 is recommended
for all Aboriginal patients prior to entry into dialysis programs.
Discontinuous use of stored BiCart dialysis concentrate does not
constitute a microbiological hazard. D. W. Johnson *, J. Dale, N. Geoige, J.
Faoagali, S.J. Fleming, Departments of Renal Medicine and Microbiology,
Royal Brisbane Hospita4 Qid, 4029. To assess the potential bacteriological
risks associated with discontinuous use of stored BiCart cartridges, total
viable microbial counts were performed on 30 specimens of water used to
prepare dialysate, 20 unused BiCart cartridges, 105 BiCart cartridges
stored wet for 48 hours following single use and 21 samples of dialysate
derived from these stored cartridges. The median bacterial counts were 89
colony forming units (CFU)/ml, 0 CFU/ml, 0 CFU/ml and <25 CFU/ml,
respectively. Corresponding cultures of liquid bicarbonate concentrate
before use (N = 75) and 48 h later (N = 75) together with 20 dialysate
samples derived from the stored concentrates, yielded median counts of 0
CFU/ml, 0 CFU/ml and 200 CFU/ml, respectively. The most common
organisms grown from all forms of dialysate or concentrate were pseudo-
monads. BiCart-derived dialysates universally complied with the standard
of 2000 CFU/ml set by the Association for the Advancement of Medical
Instrumentation (AAMI). These results indicate that discontinuous use of
BiCart cartridges after storage for up to 48 hours results in relatively low
levels of bacterial contamination of dialysate, and could result in signifi-
cant cost reductions without compromising patient safety.
The role of parvovirus infection in mediating bone marrow suppression
following renal transplantation. N. Hay*, C. Pollock, T. Chang-Zheng, D.
Morgan, J.F. Mahony, R.J. Caterson, D.A. Waugh, L.S. Ibels, Y. Cossart,
Dept. Renal Medicine, Royal North Shore Hospita4 St. Leonards NSW 2065
and Dept. Infectious Diseases, University of Sydney, NSW 2006. Human
parvovirus B19 causes a wide spectrum of diseases ranging from Fifth
Disease in children to aplastic anaemia, thrombocytopenia, arthritis and
fetal hydrops. The virus predilection for rapidly dividing cells and its tissue
tropism determined by the presence of the viral receptor (the P blood
group antigen) explain these diverse manifestations of infection. Very
prolonged anaemia due to persistent B19 infection has been described in
immune deficient patients, and this has been treated successfully with
normal pooled immunoglobulin. Recently it has been found that HIV
positive patients with thrombocytopenia have a high prevalence of B19
1gM antibody. Unexpectedly, these patients may become viraemic for B19
despite prior evidence of recovery from infection (B19 IgG). It has been
postulated that the replication of HIV may be able to provide permissive
conditions for B19 in the bone marrow, and that the viraemia may
represent reactivation of latent B19 DNA. Renal transplant patients also
suffer from refractory anaemia and thrombocytopenia and are immuno-
suppressed. In addition they may have received prior erythropoietin which
could stimulate red cell precursor turnover and allow reactivation of B19.
To seek evidence of B19 reactivation in another clinically significant
setting we have performed B19 1gM and IgG serology on pre- and
post-transplant sera from 36 patients. 24 were B19 IgG positive pre-
transplant which is comparable with the rate in blood donors. B19 1gM was
present in 9 post transplant sera and 6 of these were IgG positive earlier.
2 other patients were viraemic as judged by B19 PCR. B19 sequences are
being sought in bone marrow aspirates from patients with and without
serological evidence of virus activation or clinical bone marrow suppres-
sion.
The comparative efficacy of 3 regimes of i.v. iron dextran in haemodi-
alysis (HD) patients treated with erythropoietin (EPO). D. Saltissi*, D.
Sauvage, J. Westhuyzen, Department of Renal Medicine, Royal Brisbane and
Keperra Hospitals, Brisbane, Queensland. Uraemic anaemia is primarily
due to relative EPO deficiency. The demand for new red cells is most
marked in HD patients due to constant blood, thus iron losses. rHuEPO
administered parenterally alleviates uraemic anaemia, but the response is
blunted by several factors including most commonly, iron deficiency. In
many cases parenteral iron has been shown necessary to restore EPO
efficacy, but the optimum time course of administration is unknown. We
have performed an open randomised study of IV. Iron Dextran (Tm-
feron*) in 60 deficient patients (ferritin <100 jrg/L and/or transferrin
saturation <20%). Elemental iron was administered either as a single 600
mg bolus (A), or 100 mg weekly for 6 weeks (B), or 100 mg on 6 successive
dialyses (C) (20 patients each). Haematological response was monitored
for eight weeks. Statistical analysis indicates all 3 methods have an effect
on iron parameters, with the upward trend of Hb reaching significance
(P < 0.01). As there were no differences between the methods, single dose
infusion (method A) would seem most expedient. * Registered Trade-
mark, Fisons Pty Ltd.
Clinical and laboratory assessment of two dialyser variables: sterilisa-
tion process and porosity. PG. Kerr, A.M Corsadini 0. McGee, KC.
Wong, R.C. Atkins, Dept. of Nephrology, Monash Medical Centre, Clayton,
Vic. There are many potential dialyser variables which may influence
patient well-being and tolerance of dialysis. In an attempt to isolate two of
these factors we utilized cuprammonium dialysers in three different
conformations, 5 times each in 5 patients. The "baseline" was ethylene
oxide (ETO) sterilised, standard cuprammonium membranes. The vari-
ables included were a change to steam sterilisation (SS) and then the
addition of "high-flux" cupramnionium membranes (HF) which were also
steam sterilised. The clinical variables measured for all dialyses were BP
(pre and post dialysis), weight loss achieved, dialysis related symptoms,
and temperature rise. During the 5th dialysis instantaneous dialyser urea
clearance (measured 1 hour into dialysis at 200 mI/mm blood flow), and 132
microglobulin clearance (corrected for protein concentration, expressed
as percent reduction) were measured. Plasma was also obtained for pre
and post dialysis IL-1/3 and TNFa assessment (by ELISA). There were no
differences in BP or temperature rise between the 3 groups. There were
more symptoms with the SS group compared to the other 2 groups
(though not significant, P = 0.1). Instantaneous dialyser clearances were
significantly better with the HF dialysers (174 6 mI/mm with ETO, 178
2 with SS, and 184 1 with HF; P < 0.05 HF vs. ETO or SS). f32m
clearances were negligible with ETO and SS dialysers but were 18.6
3.5% with the HF group (P < 0.05 vs. ETO or SS). IL-1f3 and TNFn
plasma levels were mildly elevated predialysis, did not rise with dialysis,
and showed no difference between the groups. Thus steam sterilisation
alone offered no benefit in this group of patients and the high-flux version
of cuprammonium dialysers offered significantly improved urea clearances
but still only fair J32m clearance. Cytokines were not significantly induced
over the course of dialysis by any of the membranes. Choice of these more
expensive membrane variables cannot be recommended on biocompatibil-
ity grounds.
Sclerosing peritonitis—Identification of diagnostic, clinical and radio-
logical features. S. Campbell*, C. Hawley, P. Clarke, M Wigan, P. Kerlin,
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J. Butler and D. Wall, Departments of Renal Medicine, Radiology, Gastro-
enterology and Surgeiy, Princess Alexandra Hospital, Woolloongabba, Bris-
bane, 4102. Sclerosing peritonitis is a rare, but serious complication of
peritoneal dialysis. In an attempt to identify patients at risk of developing
this life-threatening problem early, we performed a cross-sectional study
of 15 patients. Five had died of sclerosing peritonitis. Four had stopped
peritoneal dialysis because sclerosing peritonitis was suspected. Six were
considered to be at increased risk because of more than four years on
peritoneal dialysis. We looked at duration of dialysis, number of episodes
of peritonitis, strength of bags, as well as type of dialysate and use of
beta-blockers. We also used a number of radiological investigations,
including abdominal x-ray, a measure of colonic transit using radio-
opaque markers, abdominal ultrasound and CT-scan. Of the clinical
features, only duration of dialysis could be shown to be an important risk
factor. We identified a number of radiological features which we believe to
be early signs of peritoneal sclerosis. The two CT-scans that were available
from deceased patients, demonstrated peritoneal thickening, as did those
in three of the four living patients who stopped peritoneal dialysis with
suspected disease, and two of the six patients on peritoneal dialysis for
over 4 years. Ultrasound demonstrated a characteristic trilaminar appear-
ance in four patients, but was unable to be demonstrated without
peritoneal fluid in situ. Delayed colon transit was demonstrated in three of
the four living patients with clinically suspected disease. Radiological
screening to detect sclerosing peritonitis early in high risk patients,
requires further study.
Anti-Nf0,, antibody in haemodialysis patients. Y-Y. Ng*, M-P. Chow,
D.C.H. Harris and T-P. Huan& Depts. of Renal Medicine, Veterans General
Hospita4 Taipe4 Taiwan and Westmead Hospital NSW 2145. The anti-
Nform antibody is produced by dialysis patients following reuse of dialysers
sterilised with formaldehyde and it has been implicated as a cause of
haemolytic anemia. Formaldehyde is one of the common disinfectants
used for reprocessing capillary haemodialysers. The safety of formalde-
hyde and the clinical significance of anti-Nform antibody need further
evaluation. Amongst 45 patients practising dialyser reuse, anti-Nrm
antibody was detected in 5 (11.1%), but not amongst 111 patients not
reusing their dialyser (P < 0.005). The presence of anti-N,,, was not
related to duration of dialysis or duration of dialysis with reused dialysers.
There was no overt haemolysis in the patients with positive anti-Nform
antibody, although significant haemolysis occurred in one patient prior to
this study. Direct Coomb's test was positive in 80% of all tested patients
with anti-Nform antibody, and in 38% of patients reusing dialysers but
without anti-Nform antibody. No test of haemolysis (including direct
Coomb's test) discriminated between anti-N,,rm antibody positive and
negative patients, nor between anti-N1,,.,,, antibody patients with and
without overt haemolysis. The best diagnostic test for haemolysis in
anti-Nform antibody positive patients is haematocrit rise after cessation of
dialyser reuse.
Evaluation of the UV-Flash germicidal exchange device for use in
peritoneal dialysis (PD). D. Saltissi*, M.J. King, Department of Renal
Medicine, Royal Brisbane and Keperra Hospitals, Brisbane, Queensland.
Numerous techniques have been devised in attempts to reduce peritonitis
incidence with chronic PD. The UV-Flash (Baxter*) is a recent develop-
ment combining automated spike-bag connection with Xenon Ultraviolet
sterilisation. In a 12 mth prospective randomised cross-over study we have
investigated peritonitis incidence and patient acceptability of the UV-
Flash compared to "other" systems. 24 new pts (13 M, 11 F; age 27—80,
mean 57 yrs) were randomly allocated UV-Flash (12 pts) or "other"
system (Ultraset 4, System III 4, CXD 4) and crossed after six months.













10 pts did not complete the two study periods, reasons will be discussed.
Numerous technical problems were initially encountered, all were even-
tually rectified. Elderly patients tended to fear the device. Cost per annum:
UV-Flash, $14,700, System III $14,000, Ultraset $20,000. We believe the
UV-Flash has a place particularly for patients with visual and manual
dexterity problems.
Low molecular weight heparin use in haemodialysis: A comparison with
standard heparin and a cost-analysis. Nicola M. Hay* and Robyn J.
Caterson, Department of Renal Medicine, Royal North Shore Hospita) St.
Leonards, NSW2O6S, Australia. A stable patient group receiving treatment
at a satellite dialysis unit was assessed with regard to anticoagulant use
during haemodialysis. Heparin is the standard anticoagulant used to
prevent clotting in the extracorporeal circuit, given as a bolus injection at
the start of dialysis followed by a continuous infusion. Low molecular
weight heparin (Fragmin') has a longer half-life allowing for more
convenient administration as a single injection given at the start of dialysis
only. No monitoring of clotting factors is required with either regimen.
Twenty-seven patients (11 males) with a mean age of 51 years (range 25 to
77) were assessed over a three month period. In the group receiving
conventional heparin (N = 18) the cost was calculated as $1.77 per dialysis
treatment, The mean "compression time" was 9.14 minutes (range
2.5—16.25). Nine patients received Fragmin', 6 receiving 2500 anti-Xa
units ($3.80) and 3 requiring 5000 anti-Xa units ($7.58). The mean
"compression time" was 8,62 minutes (range 3.8—13.3). There were no
bleeding complications with either treatment. When a patient requires
minimal anticoagulation monitoring of whole blood clotting times is
required if low dose heparin is given. This results in a significantly greater
cost of $10.92 compared to treatment with 1250 anti-Xa units of FragminR
($3.80). Our observations suggest that it is clearly not cost-effective to use
FragminR during routine haemodialysis, however, there is a cost advan-
tage when minimal anticoagulation is required. FragminR is a safe,
convenient, and effective but expensive alternative to standard heparin
used during haemodialysis.
Effect of enalapril on haemorheology in hypertensive patients with
renal disease. B.I. Shand, * R.R. Bailey, KL. Lynn and R.A. Robson,
Department of Nephrology, Christchurch Hospital Christchurch. We as-
sessed prospectively, whether the angiotensin converting enzyme inhibitor
(ACEI), enalapril, caused changes in haemorheology (blood viscosity) in
hypertensive patients with renal disease. Cellular and plasma determi-
nants of blood viscosity, renal function and blood pressure were tested at
baseline and 2, 60 and 120 days following treatment with enalapril (mean
dose 5.4; range 2.5—20 mg/day) in 19 patients with a range of renal
disorders with complicating hypertension. None of the patients was taking
other antihypertensive medication or diuretics during the study and all
other therapy remained unchanged. Approximately one-half of the pa-
tients had an abnormal baseline blood rheology profile. Within 2 days
following enalapril treatment there was a significant decrease in blood
viscosity (—0.15 mPa.s; P < 0.05), followed by a further fall of similar
magnitude by day 60, which was unchanged by day 120. The initial
decrease in blood viscosity correlated significantly with a concurrent fall in
mean plasma viscosity (r = 0.80; P = 0.001) and plasma albumin
concentration (r = 0.49;P = 0.01), indicating haemodilution had occurred
secondary to ACEI-induced vasodilatation. The later further reduction in
blood viscosity was mainly associated (r = 0.82;P = 0.001)with a small but
significant fall in haematocrit (—0.02; P = 0.01) and also to a trend of
improved red blood cell and white blood cell rheological properties. We
conclude, that enalapril has a beneficial effect on haemorheology in
patients with renal disorders. This effect is related, initially to intravascular
volume changes and subsequently, to a small decrease in haematocrit and
improved blood cell rheological properties. The decrease in blood viscos-
ity would be expected to reduce vascular resistance to blood flow and
therefore is complementary to the antihypertensive action of enalapril.
Effect of enalapril on haematological indices and plasma erythropoietin
in hypertensive patients with renal disease. B.I. Shand, * R.R. Bailey, KL.
Lynn and R.A. Robson, Department of Nephrology, Christchurch Hospital,
Christchurch. We have shown previously that angiotensin converting
enzyme inhibitors (ACEI5) cause small reductions in haematocrit in
healthy subjects, associated with a decrease in plasma erythropoietin
(EPO) concentration. We studied this effect prospectively in 19 hyperten-
sive patients (mean age 47 11 yr; 14 males) with a range of renal
diseases who were treated with enalapril. Blood samples were obtained at
baseline and at 2, 60 and 120 days following administration of enalapril
(mean dose 5.4; range 2.5—20 mg/day) and tested for haematological
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indices, plasma EPO (measured in duplicate by radioimmunoassay) and
plasma creatinine concentrations. By day 60 there was a decrease in
haemoglobin concentration (mean decrease 7.4 WI; P = 0.03) that was
sustained until day 120. The magnitude of the decrease in haemoglobin
concentration correlated significantly with the baseline plasma creatinine
concentration (r =
—0.606; P < 0.01). A decrease in plasma EPO concen-
tration occurred by day 2 (mean decrease 16.8%; P = 0.04) followed by a
return to baseline. The changes in plasma EPO concentration of individual
patients, were not related to either the dose of enalapril, baseline haemato-
logical status or renal function, or to the subsequent decrease in haematocrit.
These results suggested that the degree of renal impairment was important in
determining the magnitude of the decrease in eiythropoiesis associated with
ACE inhibition. The mechanism of these haematological changes however
remains unclear. Our findings are consistent with other studies that have
demonstrated that angiotensin II is necessary for the maximal production and
eiythropoietic action of EPO. Alternatively, an as yet unidentified factor
involved in the control of erythropoiesis may be affected by ACE inhibition.
Tubular silicon accumulation in chronic renal disease (CRD). B.J.
Nankivell*, R.A. Boadle, M. Akram, D.C.H. Hams, Dept. of Renal Medicine
& EM unit, Westmead Hospital, Sydney. Epidemiological evidence suggests
that silicon is nephrotoxic. As silicon is primarily excreted by the kidney as
silicic acid, it is possible that silicon may be involved in the progression of
CRD. The aim of this study was to determine the renal disposition of
silicon in experimental and human CRD. Tubular silicon was assessed by
energy dispersive X-ray microanalysis and quantified against a biological
standard in several models of CRD in Wistar rats, including remnant
kidney (RK), puromycin nephrosis, Adriamycin nephrosis and streptozo-
tocin diabetes. Substantial amounts of silicon were seen in uraemic RK (P
< 0.01 vs. sham), and modest amounts in the proteinuric, non-uraemic
models of renal disease at 8 weeks. In RK silicon was observed predom-
inantly in proximal tubular secondary lysosomes and tubular cytoplasm (P
<0.01 vs. background), often associated with aluminium. Silicon was seen
as early as four weeks and reached a plateau after that. In RK after six
months, silicon accumulation correlated with impairment of Tcssm GFR (r
= 0.91). Tubular damage correlated with the number of silicon-containing
lysosomes (r = 0.80, P < 0.05). Preliminary examination of human renal
biopsies also demonstrated tubular silicon accumulation in CRD (P <
0.001 vs. normal). These data suggest silicon accumulation is independent
of proteinuria, it occurs as an aluminosilicate, and may be due to the
increased load to the remaining nephrons. Although the relationship of
silicon to impairment of GFR and tubular damage is suggestive a role in
progressive CRD, further research is required to determine a causal
relationship.
Low protein diet is not protective in the remnant kidney model. *AM
Walker, N.M. Thomson, Dept. Medicine, Monash Medical School, Alfred
Hospital, Prahran, Melbourne, Vic., Australia, 3181. Low protein diet has
been demonstrated to inhibit compensatory renal growth (CRG) and slow
the development of renal failure and glomerulosclerosis in rat remnant
kidney model of chronic nonimmune injury. 12 week old, male inbred SD
underwent either 7/8 nephrectomy by infarction (Nx) or sham laparotomy
(Sh). Rats were randomly assigned to receive standard protein diet (25%
protein) (St) or low protein (8%), isocaloric diet (LP). Growth, blood
pressure and renal function was followed for 12 postoperative weeks.
Systolic blood pressure was measured by tail-cuff method and renal
function estimated by sCr, Cr. clearance and urinary protein excretion.
Animals were killed at regular intervals over a 12 week period and tissue
assessed for histological damage. Low protein diet following Nx was
associated with somatic growth failure (332 9 g LPNx, 366 8 g Nx at
9 w) and the early development of severe hypertension (200 mm Hg LPNx,
150 mm Hg StNx, 120 mm Hg LPSh & StSh) by 4 w. Renal function was
similar for the first 4 weeks but then deteriorated more rapidly in those
animals receiving the LP diet: sCr 180 75 mmol/l (LPNx), sCr 118 21
mmol/l (StNx) at 8 weeks. Most animals receiving LP diet were in end
stage renal failure by 11 w. Histological analysis revealed similar degrees
of glomerular hypertrophy between the dietary groups (47 2% glom
LPNx, 50 5% glom. StNx at 9 weeks). Percent glomeruli demonstrating
sclerosis was less in the LPNx group despite worse renal function when
compared to StNx dietary group (11 2% LPNx, 21 6% StNx at 9w).
Although there appeared to be more severe tubular damage and dilatation
in LP diet animals, tubulointerstitial index was similar between the groups.
It is unclear why dietary modification with low protein, isocaloric feed
would lead to such severe hypertension and renal deterioration following
7/8 Nx.
Cancers of the renal pelvis are more malignant when associated with
phenacetin-containing analgesics: Evidence for a carcinogenetic-promot-
ing effect of papillary necrosis. J.H. Stewart*, J.B. Hobbs and Margaret
McCredie, University of Sydney, Nepean Hospital and NSW Cancer Council,
P0 Box 63, Penrith, NSW, 2751. The histopathological slides of 101 kidneys
with pelvic cancer, drawn from a population-based sample of 147 respon-
dents to a questionnaire eliciting information concerning exposure to risk
factors for kidney cancer, were reviewed 'blind' to the exposure status of
the cases. Papillary necrosis (odds ratio—OR-—6.3), papillary calcification
(OR 3.7) and diffuse papillary scarring (OR 4.4) were significantly (P <
0.02) associated with heavy consumption (>1 kg) of phenacetin-contain-
ing analgesics, but focal papillary scarring and ureteric submucosal
capillarosclerosis were not. The overall histological (ASH) and nuclear
grades of the transitional-cell carcinomas (TCC) were significantly (P <
0.02) higher, but there was no increase in squamous metaplasia nor
squamous-cell carcinoma, in analgesic-associated cancers. Neither the
histological grade of cancer nor the degree of squamous change was
related to smoking tobacco. Multivariate logistic regression identified
female sex (OR 4.8; possibly representing confounding factors), papillary
necrosis (OR 4.7) and diffuse papillary scarring (OR 5.7), but not heavy
analgesic consumption, as independent factors significantly associated
with a higher grade of malignancy. These observations support the
concept that an important part of the carcinogenetic effect of heavy
consumption of phenacetin-containing analgesics is promotion by the
papillary damage so caused.
Pregnancy in renal transplant recipients—The Christchurch experi-
ence. KM Wong*, R.R. Bailey, KL. Lynn, R.A. Robson, Department of
Nephrology, Christchurch Hospital, Christchurch. Between July 1972 and 31
December 1992 74 women in the 15—45 yr age group had a total of 93
transplants in this institution. During this time 16 pregnancies were
recorded in 9 of these women. Fourteen of the pregnancies were planned.
These resulted in 11 live births and 3 first trimester abortions. The
remaining 2 were unplanned and were terminated. Mean age at trans-
plantation of these 9 women was 17.2 [sn 6.8; range 16—22.5] yr and mean
interval from transplant to pregnancy was 6.0 [SD 3.7; range 0.2—9.0] yr.
Thirteen pregnancies occurred in 7 women with a cadaveric kidney and 3
pregnancies in 2 women who had received a kidney from a living-related
donor. Prednisone and azathioprine were used in all patients and cyclo-
sporin in 5 of the pregnancies. For 7 of the successful pregnancies the
pre-conception plasma creatinine was 0.10 mmol/l and was unchanged
after delivery. One of these women developed chronic rejection 5 yr after
delivery and reached endstage renal failure 9 yr later. For the other 4
successful pregnancies the pre-conception plasma creatinine was 0.12 to
0.14 mmol/l. One of these patients halved her renal function, but this has
remained stable for 15 yr. 1 poorly compliant woman developed chronic
rejection after delivery and reached endstage renal failure 2 yr later, 1
developed cyclosporin toxicity and the other was unchanged. Six deliveries
were by elective caesarean section, 4 by urgent caesarean section and 1 by
vaginal delivery. There were no congenital anomalies or perinatal mortal-
ity. One infant died aged 4 mth from a cot death. We recommend that if
a woman has had a stable renal transplant for >2 yr, graft function is
normal, and BP well controlled then there is no contraindication to her
having a pregnancy which should be managed by shared obstetrical/
nephrological care.
Cutaneous manifestations of renal transplantation in a New Zealand
population. D.J. Hepburn, D. Divakar, R.R. Bailey", KJ.S. Macdonald,
Departments of Dermatology and Nephrology, Christchurch Hospital,
Christchurch. Long-term immunosuppressive therapy is essential following
organ transplantation. This increases the rate of cutaneous infection and
malignancy. We have documented our experience with 52 stable renal
transplant recipients (27 males; mean age 43.5 [SD 12.0] yr; mean duration
of immunosuppression 115.6 [SD 70.6] mth; range 3—258 mth) from a
temperate maritime climate, latitude 42°S, with regard to sun exposure,
skin type and human papillomavirus (HPV) type of clinically apparent
warts. All skin infections were characterised and miscellaneous cutaneous
lesions recorded. Thirty-seven patients were on a regimen of prednisone
and azathioprine and the remaining 18 on prednisone, azathioprine and
cyclosporin. Forty-three (84%) were regular users of sunblock with a sun
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protection factor rating of  15. Premalignant and malignant lesions were
common (20 actinic keratoses, 3 BCC, 2 KA, 1 melanoma). Including prior
observations 48 cutaneous malignancies were identified in 9 patients.
Squamous cell carcinoma outnumbered basal cell carcinoma by a ratio of
1.2:1. No metastases were recorded. Non-neoplastic lesions were also
documented including the prevalence of HPV infection. There was a
significant correlation between the development of skin cancer after
transplantation and total sun exposure (P < 0.05),clinically apparent wart
infection (P < 0.05), and the duration of unmunosuppression (P < 0.01).
Renal transplant recipients require regular skin examination. High risk
patients for skin cancer should be identified as they require intensive
dermatological follow up.
Mechanisms of glomerular neutrophil recruitment in a complement
independent model of glomerulonephritis. P. G. Tipping XK Huang, S.R.
Holdsworth, Monash University, Dept. of Medicine, Monash Medical Centre,
Clayton 3168. Neutrophil recruitment and lung injuiy following comple-
ment activation has been demonstrated to be dependent on endothelial
expression of P selectin. In anti-glomerular basement membrane antibody
induced glomerulonephritis (anti-GBM GN) in mice, acute glomerular
injury results from complement independent, neutrophil accumulation.
The signals for neutrophil recruitment in this model are unknown.
Expression of P selectin on glomerular endothelium was demonstrated
within 30 minutes of administration of anti-GBM antibody to C57/BL1O
mice. This was associated with rapid accumulation of neutrophils in
glomeruli which peaked at 1 hour (6.2 0.5 neutrophils per glomerular
cross section [neut/gcs], normal 0.34 0.06 neut/gcs, P < 0.01) and
significant proteinuria after 16 hours (3.6 0.5 mg/16h, control 0.62
0.13 mg/16h, P < 0.01). Complement depletion with cobra venom factor,
which reduced serum C3 levels to less than 5% of normal, did not alter
expression of P selectin, reduce glomerular neutrophil accumulation (6.7
0.8 neut/ges) or proteinuria (3.7 0.5 mg/16h). Platelet depletion also
failed to alter glomerular expression of P selectin, neutrophil accumula-
tion or the development of proteinuria. Mice were treated with an affinity
purified anti-human P selectin antibody, which crossreacted with mouse P
selectin and blocked P selectin dependent binding of thrombin activated
mouse platelets to HL6O cells. Treatment, 1 hour prior to administration
of anti-GBM antibody, markedly inhibited glomerular neutrophil accumu-
lation (0.94 0.12 neut/gcs) and prevented proteinuria (1.0 0.2
mg/16h), and did not alter binding of anti-GBM globulin in the kidney.
These data strongly suggest that the rapid upregulation of P selectin
expression in glomeruli following binding of anti-GBM antibody is an
essential signal for neutrophil recruitment in this complement indepen-
dent model of glomerular injury.
Suppression of established rat crescentic glomerulonephritis (GN) by
the interleukin-1 receptor antagonist (IL-ira). H.Y. Lan, D.J. Nikolic-
Paterson, W. Mu, R. C. Atkins, Dept. of Nephrology, Monash Medical Centre,
Clayton Vic 3168, Australia. We have previously demonstrated that IL-ira
treatment from the time of anti-GBM serum injection suppressed the
development of accelerated rat anti-GBM GN. The current study inves-
tigated whether IL-ira treatment could intervene in established crescentic
GN. Accelerated anti-GBM GN was induced in inbred Sprague-Dawley
rats by priming with 5 mg normal rabbit IgG and injection of rabbit
anti-rat GBM serum 5 days later (day 0). One group of 6 rats received a
constant subcutaneous infusion of IL-ira from day 7 until being killed at
day 21. Control animals have the same experimental schedule but received
saline only (untreated). Blood and urine samples were taken on days 0, 1,
7, 14, and 21. Leukocyte infiltration was assessed by immunoperoxidase
staining with monoclonal antibodies. Saline treated animals showed
marked disease progression over days 7 to 21 which was significantly
reduced by IL-ira treatment. Specifically, IL-ira treatment reduced
hematuria (P < 0.001), proteinuria (P < 0.05), and plasma creatinine
while improving creatinine clearance (P < 0.05, by ANOVA). Histologi-
cally, IL-ira treatment markedly reduced glomerular hypercellularity and
segmental sclerosis ( , 50%,P <0.01),cell proliferation ( 53% of PCNA
cells/gcs, P < 0.001), glomerular crescents (58.5 4.9% vs. 25 3.6%,P
<0.01), and tubulointerstitial fibrosis (P < 0.05). Immunohistologically,
IL-ira treatment suppressed glomerular ( t. 42%, P < 0.01) and interstitial
(1. 64%, P < 0.001) macrophage accumulation and interstitial T cell
accumulation (,j, 37%, P < 0.01). Importantly, IL-ira suppressed intersti-
tial mononuclear cell activation (J, 64% IL-2R cells, P < 0.01). This study
demonstrates that IL-ira can intervene in progressive renal injury in
experimental crescentic GN.
Reactive oxygen species (ROS) and lipid peroxidation (LPO) in pro-
teinuric experimental renal disease. TJ. Neale*, D. Kerjaschki#, J. Witz-
tumt, P. Davis, B. Ruger, Dept. of Medicine, Wellington School of Medicine,
#Institute of Pathology, University of Vienna and fDepartment of Medicine,
UCSD, San Diego. ROS are implicated in the pathogenesis of experimen-
tal glomerular injury. In proteinuric passive Heymann's nephritis (PHN),
glomerular epithelial cells (GEC) show heightened expression of cyto-
chrome b558, a component of the respiratory burst oxidoreductase that
produces ROS (Proc NatlAcad Scj USA 90:3645—3649, 1993). Cytochrome
b558 also showed increased expression in the GEC of amminonucleoside
nephrosis (AN) rats, by monoclonal IF microscopy and immunoblotting of
isolated glomerular extracts. There was marked upregulation of cyto-
chrome mRNA by Northern blotting. H2O2 was localised by EM within
the glomerular capillary wall using ex vivo perfusion with cerium. In
proteinuric AN and PHN glomeruli malondialdehyde (MDA) was re-
vealed as a marker of LPO with antibody specific for MDA-lysine adducts
by IF microscopy, immunogold EM and immunoblotting. MDA was
present on cell membranes, within GEC vesicles and associated with
GBMs. Type IV collagen was a recipient of MDA adducts as shown by
autoradiography of immunoprecipitates of isolated GBMs from protein-
uric PHN rats which were specifically H3-Iabelled in their MDA-deriva-
tised proteins. Anti-MDA antibody bound to type IV collagen immuno-
precipitated from glomerular extracts. Collagenase treatment of GBM
extracts indicated that the NC-i domain of type IV collagen was a site of
adduct formation. Inhibition of LPO in vivo by pretreatment of rats with
the lipophilic antioxidant probucol markedly abrogated proteinuria com-
pared to controls in both models: (PHN: 24.8 8.0 versus 161 24 mg
per 24 hrs; P = <0.05; AN 28 6 versus 186 8mgper 24 hrs; P <0.01).
The glomerular IF signal for, and whole kidney [MDAJ (P < 0.01) were
markedly reduced compared to controls. These findings strongly implicate
LPO in the production of the altered glomerular permselectivity that
results in proteinuria in PHN and AN.
Expression of the SGP-2 gene in renal regeneration—Continuing
evidence for links with apoptosis. G.C. Gobé*, R. Buttyan#, KR.L.
Wybuni, MR. Etheridge and P.J. Smith, Dept. of Pathology, Medical Schoo4
University of Queensland, Brisbane, 4006 and #Dept. of Urology, Columbia
University, New York 10032, USA. The sulphated glycoprotein-2 (SGP-2)
gene has a role in acute and chronic renal injury that is not well
understood. Its increased expression is often associated with presence of
apoptosis, but some reports demonstrate links with the renal regenerative
response found after toxin- or ischaemia-induced acute tubular necrosis.
We have used a novel rodent model of renal regeneration to study SGP-2
expression and intrarenal distribution. The model involved initial devel-
opment of unilateral non-infarctive renal atrophy using experimental renal
artery stenosis, followed by contralateral nephrectomy after several weeks.
Regeneration of remnant atrophic kidneys was rapid and involved renal
cellular hyperplasia rather than hypertrophy. At the time of induction of
regeneration, cellular pathology of atrophic kidneys comprised regions of
shrunken de-differentiated tubules, an expanded interstitium, and focal
hypertrophied but otherwise normal tubules. Apoptosis, which is known to
play a major role in earlier development of renal atrophy, was rarely
visible, and there was little inflammation. Regenerating renal tissue from
male rats (N = 2 or 3) was studied at 0, 4, 8, 24 hours, 2, 3, 5, 7, and 14
days after contralateral nephrectomy. Control animals were sham-oper-
ated (N = 2). Several parameters were studied: level and localisation
SGP-2 expression (Northern blots and in situ hybridisation); cell prolifer-
ation (PCNA immunolocalisation and histological identification of mito-
sis); and apoptosis (morphological characteristics). During the acute
regenerative phase (first 24 hours) expression of SGP-2 was increased,
decreasing to untraceable levels by 3 days. Expression was localised most
often in dc-differentiated atrophic tubules, or the periphery of vessel walls.
PCNA counts peaked at 5 days, with epithelial cells of dc-differentiated
atrophic tubules again most active. Despite the regenerative stimulus, an
unexpected but marked transient increase in apoptosis was found in
atrophic tubules in the first 2 days. Thus, the results provide evidence that
increased expression of SGP-2 is associated with apoptosis rather than
regeneration, but a role in restructuring of the atrophic tissue cannot be
ruled out. The results also suggest that this model may be useful for
studying other early genetic changes found in renal neoplasia.
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Regulation of the integrin fibronectin receptor a5j31. Implications for
mononuclear cell accumulation at sites of inflammation. RandallJ. Faull*
and Mark H. Ginsberg, Department of Renal Medicine, St. George Hospital,
Kogarah, NSW, 2217, and Committee on Vascular Biology, The Scnpps
Research Institute, La Jolla, California. Disorders dependent on mononu-
clear cell accumulation at inflammatory sites are frequently encountered
in nephrology. They include rejection of allografts, vasculitis, glomerulo-
nephritis, tubulo-interstitial nephritis and pyelonephritis. Cells migrating
from the blood to these sites undergo repeated cycles of attachment!
detachment to the vascular endothelial cells and the extracellular-matrix.
Principal among the cell surface receptors mediating these interactions
are members of the integrin superfamily of adhesion molecules, including
the "classical" fibronectin receptor a5f34. We have studied the regulation
of a51 function on mononuclear cells in order to assess its contribution to
this process of extravasation and accumulation. A monoclonal antibody
(8A2) directed against the j3 chain directly activated the a51 receptors,
converting them from a conformation with low affinity for soluble fi-
bronectin (Kd > 1 tM) to one with high affinity (Kd 40 nM). In the
presence of soluble fibronectin at a concentration found in normal plasma
(700 nM), these high affinity receptors were occupied and unable to
mediate adhesion of T lymphoid cells to immobilised fibronectin. In
contrast, stimulation of protein kinase C in T lymphoid cells with phorbol
myristate acetate increased adhesion to fibronectin by inducing cell
spreading. As the receptors remained in a low affinity conformation, the
increase in adhesion was not blocked by soluble fibronectin. The findings
suggest that only the low affinity receptors are available for adhesion in the
presence of physiological concentrations of soluble fibronectin. Both
forms of the a31 are presumably physiologically relevant, as differentia-
tion of monocytoid cells (THP-1) into adherent, macrophage-like cells
induced a subpopulation (30%) of high affinity a5f31 receptors. We
hypothesize that: (1) mononuclear cells use the low affinity a5f31 receptors
for the reversible interactions required during migration into inflamma-
tory foci; and (2) the high affinity receptors induced by the subsequent
differentiation bind soluble fibronectin, enabling the cells to assemble a
stabilising fibronectin matrix and hence persist at those sites.
Glomerular expression of ICAM-1 and VCAM-i in EXHC rats: A model
for lipid-induced glomerular injury. M. Hattori', D.J. Nikolic-Paterson',
H. V. Lan', P.A. Hill2, H. Kawaguchi3, K Ito3, R. C. Atkins', Dept. of
Nephrology, Monash Medical Centre'; Dept. of Anatomy, University of
Melbourne2; and Dept. of Pediatric Nephrology, Tokyo Women s Medical
College3. A number of studies have demonstrated an important role for
macrophages (M4) in lipid-induced glomerular injury; however, little is
known of the mechanisms which mediate M4 infiltration in this disease.
The present study examined whether adhesion molecules ICAM-1 and
VCAM-1 may be involved in glomerular M4i infiltration in ExHC rats—a
strain which is susceptible to lipid-induced glomerular injury (Nephron
63:314, 1993). Twenty-five male 6 week old ExHC rats were placed on a
normal diet supplemented with 3% cholesterol, 0.6% sodium cholate and
15% olive oil (HCD). Groups of 5 rats were killed after 3 days, 1, 2, and
6 weeks on HCD diet. A group of 5 matched ExHC rats on a normal diet
served as a control. HCD rats showed marked hypercholesterolemia in the
absence of any increase in plasma triglyceride levels from day 3 (190 14
vs. 41 3 mg/dl normal; P < 0.01), and developed mild proteinuria (21.9
2.7 vs. 5.2 0.5 mg/24 hours normal; P < 0.01) and segmental
glomerular lesions at week 6. Immunoperoxidase staining identified a
significant increase in glomerular ED1 + M4 at week 1 which was further
increased at week 6 (6.9 0.4 vs. 1.0 0.1 ED1+/gcs normal; P < 0.01).
There was also a significant increase in glomerular cells expressing the
adhesion molecule ligands LFA-i and VLA-4. Coincident with M4
infiltration there was an increase in glomerular anti-ICAM-1 staining in
both the number of positive cells and the intensity of staining. Northern
blot analysis of cortical RNA found an increase in both ICAM-i and
VCAM-1 mRNA from day 3 onwards. In conclusion, these results suggest
that upregulation of ICAM-1 and VCAM-1 expression may play an
important role in lipid-induced glomerular M infiltration.
Plasminogen activator inhibitor type-i in rabbit crescentic glomerulo-
nephritis: Assessment of function and association with fibrin deposition.
J.H. Erlich*, J. Malliaros, J.A. Apostolopoulos, SR. Holdsworth & PG.
Tipping, Department of Medicine, Monash University, Clayton, Vic 3168,
Australia. Plasminogen activator type-i (PAl-i) is a naturally occurring
rapidly acting inhibitor of the plasminogen activators—tissue plasminogen
activator (t-PA) and urokinase plasminogen activator (u-PA). Endothelial
cells are a major source of PAL-i. The role of PAL-i in antiglomerular
basement membrane (anti-GBM) glomerulonephritis (GN) was investi-
gated in a rabbit model of anti-GBM GN characterised by: proteinuria,
renal impairment, crescent formation, fibrin deposition and macrophage
influx. Rabbits were presensitised with a subcutaneous injection of normal
horse immunoglobulin followed 5 days later by 25 mg/kg of horse
anti-rabbit-GBM antibody intravenously. Renal tissue was collected after
1, 4, 7, and 12 days. Fibrin deposition in isolated rabbit glomeruli was
assessed following injection of 1251-fibrinogen and by fibrinogen immuno-
fluorescence in rabbit renal cortical sections. At each time point PAl-i
activity was assessed in conditioned medium of cultured glomeruli using a
urokinase functional inhibition assay and PAl-i mRNA expression was
determined using RNA isolated immediately from glomeruli. PAL-i
activity in glomeruli was increased on days 4 (291 18 au) (mean saM)
and day 7 (213 27 au) (P < 0.05 cf normal 112 38 au). This correlated
with an increase in glomerular PAl-i mRNA which was also increased on
days 4 (123.4 7.3) and 7 (133 2.6) (P < 0.084 day 4 cf normal; P <
0.021 day 7 cf normal). The increase in PAl-i activity and mRNA showed
the same temporal pattern as glomerular fibrin accumulation and macro-
phage infiltration on days 4 (21.8 3.3 g/10' glomeruli) and day 7 (20.0
2,5
.tg/10' glomeruli) (P < 0.05 cf normal 1.5 0.5 .rg/i03 glomeruli).
This close temporal correlation between glomerular PAL-i function,
mRNA expression, fibrin deposition and macrophage influx suggest a role
for PAl-i in gloinerular fibrin accumulation. The augmentation of gb-
merular PAL-i may be directed by macrophages.
Lipid peroxidation in puromycin aminonucleoside (PAN) induced
nephropathy. J.P. Fawcett, R. Jiang; R.J. Walker*, Medicine Dept., Otago
Medical School, Dunedin, NZ. Reactive oxygen species producing lipid
peroxidation have been implicated in the pathogenesis of acute PAN-
induced nephropathy. Proteinuria has been used as the marker of
glomerular injury. No studies have determined the relationship/time
course of lipid peroxidation with the development of proteinuria. Rats
were treated with a single IV injection of PAN (7.5 mg/kg). 24 hour urine
protein excretion (mg/24 h) was determined prior to sacrifice on days 2, 3,
5, 7, 10, i7, 27, 41 (N = 5—10 per group). The kidneys were removed and
flushed with ice cold TRIS buffer. Kidney cortices were homogenised
individually. Tissue lipid peroxidation (TBARS ng/mg protein) was mea-
sured in whole homogenates and lipid extracts by the thiobarbituric acid
assay (HPLC & spectrophotometric determination). N = 5—10 rats, * p <
0.05 vs. control.
Day 0 2 3 4 5 7 10 17 27 41
Tissue
peroxidation
Mean 58.4 94.1* 114* 128* 96.5* 81.1* 77.5 70.8 73.9 78.6




Mean 29.7 36.4* 48.0* 37.0* 32.6* 27.1 34.7 24.7 29.2 22.3
SEM 6.0 3.6 2.3 5.1 5.1 4.6 2.9 6.5 6.6 2.2
Proteinuria
Mean 1.2 1.3 1.9 * 102* 220* 203* 121* 15.3* 10.7*
SEM 0.4 0.2 0.6 13 14 30 20 13 53 4.8
Peak lipid peroxidation occurred 48 hours prior to the development of
proteinuria. This study supports the role of lipid peroxidation mediating
the glomerular injury in PAN nephropathy and defines the relationship
between peroxidative injury and the development of proteinuria.
Energy expenditure in children with chronic renal failure. E.E. Reed*,
J.C. McCauley, L.P. Roy, KJ. Gaskin and J.F. Knight, Department of
Nephrology and James Fairfax Institute of Paediatric Clinical Nutrition, The
Children's Hospital Camperdown, NSW, Australia, 2050. Energy intake is
often poor in children with chronic renal failure. In order to provide
optimal nutrition, it is necessary to know the energy requirements of this
group. The aim of this study is to determine the resting energy expenditure
(REE) in a group of children with glomerular filtration rate (GFR) <30
mI/mm/i .73 m2 and to compare this with the predicted REE according to
921 Abstracts
Schofield1. REE was measured with a flow through ventilated hood open
circuit indirect calorimeter in six children after an overnight fast. Energy
intake, measured by a 4 day weighed food record, was compared to
WHO/FAO recommended energy intake for age. Mean age was 10.8
years, mean height standard deviation score (SDS) was —1.75 and mean
weight SDS was —1.06. The mean REE was 98.1% of the predicted REE.
Mean energy intake was 88.6% of recommended. Resting energy expen-
diture is normal in these children with chronic renal failure. However
energy intake is below that recommended for children with a normal REE.
Malnutrition and growth failure may result if energy intake is not
increased to meet energy expenditure. Nutritional support for children
with renal failure should be planned to provide the recommended energy
intake for age.
1. SCHOFIELD WH, ET AL.: Basal metabolic rate—review and prediction.
Human Nutrition: Clinical Nutrition 39C:1—96, 1985
Amyloidosis among Central Australian Aborigines. MG. Kirubakaran*,
N Rajabalendran and L. Mollison, Department of Medicine, Alice Springs
Hospital, Alice Springs, NT—0870. The incidence of amyloidosis varies
greatly between different ethnic groups throughout the world and it is
particularly high in the Aboriginal population of Central Australia.
Nineteen new cases of amyloidosis were detected during a six year period
among a population of 13,200 Aborigines in Central Australia, giving an
incidence of 240 cases per million per year. The mean age was 43.5 years
(range 26—72) and 11 were females. The main presenting symptom was
acute abdomen with pseudo-obstruction in 12 cases, five of whom had
exploratory laparotomy prior to diagnosis. Multiple organisms were grown
from the peritoneal fluid in all 5 cases. The diagnosis of amyloidosis was
established by renal biopsy in 9 cases, rectal biopsy in 7 and at post
mortem in 3. The amyloid was AA type in all cases but chronic infection
was present only in 4 cases (pulmonary tuberculosis, chronic osteomyelitis,
lepromatous leprosy and extensive donovanosis—1 case each). Eleven
patients have died, 8 within 6 months of onset of symptoms. Overwhelm-
ing infection with multisystem failure was the main cause of death,
aggravated by malabsorption and malnutrition. Post mortem findings were
similar all cases available for autopsy with widespread amyloid deposits in
all the internal organs. End stage renal failure developed in 8 patients, all
of whom were commenced on dialysis, and two have been transplanted.
The Central Australian Aborigines have a very high incidence of AA type
of amyloidosis and the aetiology remains obscure in most of them. The
disease appears to have a fulminant course with high mortality and
morbidity.
Validation of screening of children for renal abnormalities. S.J. Hams',
MP. Dixit, R.J. Hog,g P.H. Henning, N Wigg & KF. Jureidini, Renal Unit,
Women's & Children's Hospital and Child Adolescent Family Health Serv-
ices , Adelaide, South Australia 5006. We have previously screened 8764
kindergarten children for renal abnormalities by measuring BP, growth
percentiles and testing frozen first morning urine for blood, protein,
glucose, osmolality, nitrites and f32-microglobulin. 978 (11.3%) of these
showed abnormalities and were reviewed in the renal clinic with full
history and examination, repeat urine assays and renal ultrasound, where
indicated. Of these, 86 (8.8%) were ultimately shown to have significant
abnormalities. Screening has been performed on a further 690 kindergar-
ten children. Of these 77 (11.3%) initially screened abnormal and 11
(14.3%) were ultimately proven significantly abnormal. 347 children,
normal on initial screen, were recalled. On review in the renal clinic, 2
(0.6%) were proven to have significant abnormalities (one had dominant
polycystic kidneys with a positive family history, normal BP and urinalysis
and the other a normotensive co-arctation of the aorta with obviously
diminished femoral pulses on examination). The study shows a significant
difference in ultimate diagnosis of renal abnormalities between those
showing changes on the primary screen compared with those who do not
(8.8% cf 0.6%, P < 0.001). This, coupled with the similar abnormality rate
in this recent screening compared with the previous larger study, suggests
the validity of our screening methods.
Haematuria and urinary red blood cell morphology. P. Sizeland*, R.R.
Bailey, B. Harns Departments of Nephrology and Microbiology, Christchurch
Hospital. Urinary red blood cell (rbc) morphology is widely used in the
evaluation of haematuria. Some concerns persist with the technique,
however, including the lack of a precise classification of rbc morphology
and the proportion of cells with abnormal morphology that constitutes
glomerular haematuria. Using a recently described morphological classi-
fication (Tomita et al., Clin Nephrol 37:84—9, 1992), we evaluated the
technique in the differential diagnosis of urinary tract haematuria. Results









Using readily available laboratory results (proteinuria, casts, plasma
creatinine), in addition to urinary rbc morphology, improved precision as








We conclude that:—(1) urinary rbc morphology is a useful but not
definitive tool in the assessment of a patient with haematuria, (2) urinary
rbc morphology should be used in conjunction with other available
laboratory results.
Childhood factors in aboriginal renal disease. *D.,4. McCredie, B. Craig,
W. Hoy, J.D. Mathews and R. McFarlane, Menzies School of Health
Research and Royal Darwin Hospital, P0 Box 41096, Casuarina, Northern
Tenitoty 0811, Australia. Children from an aboriginal community in the far
north of Australia are being followed-up as part of a longitudinal study to
investigate possible aetiological factors in the development of chronic
renal disease, which affects up to half of the adult population of this
community. Data on 219 children, aged 6 to 16 years, have been collected,
representing three quarters of the school-age population, with particular
reference to nutrition, history of infections, presence of skin sores, blood
pressure, urine examination, bacterial isolation from skin and throat and
streptococcal antibody titres. Significant haematuria on dipstick testing
was found in 31 children (14%) and proteinuria in nine (4%), with
abnormal urine albumin creatinine ratios (>5 mgfmmol) in seven. Only
two children had both blood and protein in urine. Malnutrition by
European standards, and a high infection rate (particularly of chest and
skin) were prevalent, especially in early life, but showed no correlation
with haematuria or proteinuria. Likewise there was no correlation be-
tween indices of renal disease and isolation of Group A Streptococcus
pyogenes (25% of children), high streptococcal antibody titres (almost
universal), or a past history of post-streptococcal glomerulonephritis (26
children). The only significant correlation was that of proteinuria with age.
Only three of 160 children less than 13 years had proteinuria, compared
with six of 59 aged 13 to 16 years [P < 0.01]. This proportion increases to
27% in the third decade of life, and reaches almost 50% by the age of 40
years. These preliminary results suggest that proteinuria, implying signif-
icant renal disease, is becoming appreciable by the early teenage years
though a relationship to the presence of haematuria in earlier years has
not been shown. Follow-up of these children is continuing in the hope of
identifying predictive factors in the development and progression of renal
disease.
Aerotolerant coryneforms as urinary tract pathogens. R.R. Bailey*, B.
Hams, Departments of Nephrology and Microbiology, Christchurch Hospital,
Christchurch. Most urinary tract infections in clinical practice are due to
Enterobacteriaceae. It is well documented that mycobacterial, fungal, viral
and other atypical organisms may invade the urinary tract. Recently we
have seen a number of patients with unequivocal colonisation of the
urinary tract with an aerotolerant coryneform. All had heavy pyuria. The
clinical details are included in the table.
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Underlying
No. Age Sex problem Presentation
1 42 F Reflux nephropathy Acute pyelonephritis




3 83 F Large residual
urine
Asymptomatic
4 85 M Myelofibrosis, renal
failure, TURP
Asymptomatic
5 78 M Recurrent UTIs Asymptomatic
6 72 F Demented,
incontinent
Asymptomatic
The finding of aerotolerant coryneforms growing in voided urine imme-
diately suggests contamination during the collection process. However, in
4 of these 6 patients there was unequivocal colonisation of the urinary
tract proven with urine obtained by suprapubic aspiration or catheterisa-
tion. Although 5 of these patients were elderly, none had any evidence of
associated bowel or gynaecological problems. If patients have a urinary
tract abnormality and pyuria and nothing is cultured with conventional
techniques, then consideration should be given to culturing for this group
of pathogens.
Prednisolone (PNL) decreases haematuria in IgA nephropathy. K
Nicholls*, P. Kincaid-Smith, G. Becker, Dept. of Nephrology, Royal Mel-
bourne Hospital, Parkville 3050. Thirty-three patients with biopsy proven
IgA nephropathy and urinary erythrocyte count (URBC) consistently
>10' on 3 occasions over 3 months entered a prospective controlled trial
of PNL therapy. Patients were randomly allocated to no additional
therapy or PNL (25 mg daily, for 4 weeks, decreasing to 12.5 mg daily by
6 weeks, then to 10 mg daily from 6—12 months). All patients were
reviewed at 1, 3, 6, 9, 12 & 15 months, and clinical parameters, urinary
erythrocyte counts, proteinuria and creatinine clearance were recorded.
Tc-DTPA renal scans with GFR were obtained at the beginning and end
of the study. Four patients (3PNL) were withdrawn during the study, for
steroid induced diabetes 1, non-compliance 2, Cr 0.50 mmol/l 2. Both
patient groups were well matched for age, renal function and URBC at
entry. Results:
Median URBC X 105/mL






















* P = 0.03 Wilcoxin
No effect of PNL on renal function or proteinuria was demonstrated. We
conclude that PNL significantly decreases URBC, but that this effect is not
sustained as the dose is decreased to acceptable maintenance levels.
Oxidisability of low density lipoprotein in patients on renal replace-
ment therapy. KC. Wong', M Luo2, R. O'Brien2, N. Balazs3, C.J. Wood',
P.G. Kerr', R.C. Atkins', Depts. of Nephrology'/Medicine2/Biochemist,y3,
Monash Medical Centre, Clayton I/ic 3168. In vitro evidence suggests that
oxidative modification of Low Density Lipoprotein (LDL) plays an
important role in atherogenesis. The potential influence of treatment
modality for renal failure on the oxidisability of LDL has not been studied
previously. We measured the susceptibility of LDL to oxidation in 27
healthy controls (C), 17 CAPD patients (PD), 20 haemodialysis patients
(HD) and 19 kidney transplant recipients (KidTx) using in vitro oxidation
with copper. This is expressed as lag time (mm) between addition of
copper and commencement of oxidation. The change in Absorbance
represents conjugated diene formation and correlates with the presence of
products of oxidation. Thus, a long Lag phase and low A Absorbance are
associated with a lower risk of atherogenesis. HD and PD patients had
higher Triglyceride levels than C (P = 0.03,P = 0.01 respectively). KidTx
had lower Triglyceride levels than PD (P = 0.01) and a trend for lower
Triglyceride levels than HD. KidTx had higher Cholesterol levels (P =
0.001) when compared with HD. There was no difference in the Lag time
between HD, PD, and C. HD had increased products of oxidation as
measured by A Absorbance (P = 0.0002 ci C and P < 0.0001 cf PD). It is
possible that the Haemodialysis procedure itself may contribute to a lower
antioxidant state and thus result in increased lipid peroxidation in this
group of patients. With the restoration of renal function after transplan-
tation, the elevated A Absorbance returns to normal. This may contribute
to a reduction in atherogenicity and vascular disease.
Cholesteryl ester transfer (CET) activity in patients with chronic renal
failure (CRF). J. Corboy, W.H.F. Sutherland, R.J. Walker*, MC. Robertson,
CM. Cox, Department of Medicine, Otago Medical School, Dunedin, NZ.
Patients with renal failure have an increased risk of atherosclerosis in part
due to lipid and lipoprotein abnormalities. Alterations in reverse choles-
terol transport may contribute to the increased risk. CET protein catalyses
the redistribution of newly synthesised cholesteryl esters (CE) from HDL
to other apo-B lipoproteins. The effects of renal therapy on CET activity
have not been fully studied. Plasma CET was determined by measuring the
accumulation in apo-B lipoproteins of CE generated from plasma free
3H-cholesterol. 53 patients (ages 15—77) were studied. 13 were dialysis
independent, 12—haemodialysis, 11—CAPD, 17—renal transplants.
Plasma CET rate (nmol/ml/hr)
DI HD CAPD RT Control
Normolipidaemic 20.7 2.7 19.5 4.2 22.0 3.6 22.9 6.2 18.0 5.6
Hyperlipidaemic 27.6 9.7 29.2 13.0 36.3 12.5 32.4 11.7 27. 7.6
Total 25.5 10.5 24.4 10.5 32.4* 12.5 27.9 10.4 22.1 7.9
Apo B (g/l) 0.97 0.31 0.95 0.32 1.33** 0.34 0.99 0.3 0.87 0.2
P < 0.05 ANOVA with control; ** P < 0.01 ANOVA compared to all
groups
Plasma CET rate was higher in hyperlipidemic subjects with the highest
rates in the CAPD group. In the normolipidemic subjects there was no
difference compared to controls. Plasma apo-B levels correlated with CET
rates in all renal patients (r = 0.754 P < 0.001). This study shows that
plasma CET rate is closely associated with apo-B and lipid levels
irrespective of treatment modality. Raised CET activity may not be
inevitable in CRF as activity was normal in absence of hyperlipidemia.
What influence lipid lowering therapy may have on plasma CET activity in
hyperlipidemic patients with CRF warrents further investigation.
Lipoprotein (a) and other potentially atherogenic lipids in maintenance
dialysis and renal transplantation. L.S. Ibels*, C.A. Pollock; C.S. Ong, R.J.
Caterson, D.A. Waugh, J.F. Mahony, Department of Renal Medicine Royal
North Shore Hospital St. Leonards, 2065, Australia. Serum lipids and
lipoprotein (a) concentrations were measured in 91 renal transplant and
60 dialysis patients, and correlations sought with manifest vascular disease.
Serum lipoprotein (a) concentrations were greater than 300 mg/I in 24%
of the renal transplant recipients and 40% of the dialysis patients, and
other potentially atherogenic lipid abnormalities were very prevalent. In
the renal transplant recipients, lipoprotein (a) correlated with age (P <
0.001) and inversely with azathioprine dosage (P < 0.01). Low HDL
cholesterol concentrations (P < 0.05) and high total cholesterol to HDL
cholesterol ratios (P < 0.01) were more strongly associated with the
presence of vascular disease than was elevated lipoprotein (a). In the
dialysis patients, a low serum albumin (P < 0.05) and a low serum
creatinine (P < 0.001), indicative of a poor nutritional state, were
associated with the presence of vascular disease. A high total serum
cholesterol to HDL cholesterol ratio (P < 0.05) was indicative of
ischaemic heart disease, and a high total serum cholesterol (P < 0.01) and
LDL cholesterol (P < 0.01) of cerebrovascular disease. Although patients
on CAPD (N = 21) tended to have higher serum lipoprotein (a) compared
with patients on haemodialysis (N = 39), i.e. 403 76 vs. 260 37 mg/I,
the differences were not significant (P = 0.11). In CAPD patients, serum
lipoprotein (a) correlated with total serum cholesterol (P < 0.05) and the
LDL subfraction (P < 0.05). Elevated serum lipoprotein (a) levels were
associated with cerebrovascular disease in the CAPD patients (P < 0.01).
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In both the transplant and dialysis populations no associations of serum
lipoprotein (a) were seen with sex, duration of dialysis prior to transplan-
tation, presence of diabetes mellitus or smoking. The present study
demonstrates that an elevation in serum lipoprotein (a) concentration is
very prevalent in patients on renal replacement therapy, but is not as
strongly associated with the presence of vascular disease as are the total
serum cholesterol, HDL and LDL cholesterol levels and the ratio of total
cholesterol to HDL cholesterol.
Successful self-care home dialysis in the elderly: A single centre's
experience. M. McDonald, P.D. McPhee, R.J. Walker, Department of
Nephrology, Dunedin Hospital, Dunedin, New Zealand. The increasing
number of older people in the population has been associated with an
increased incidence of renal failure and higher acceptance rates for renal
replacement therapy in New Zealand and Australia. We have analysed
prospectively our unit's experience with renal replacement therapy in the
60 years and older age group since the introduction of CAPD in 1989.
There were 25 patients (21 Caucasians, 3 Maori, 1 Cambodian—16 males,
9 females) with an average age of 64.4 years (range 58.25—76.5 years at the
commencement of dialysis). They made up 34% of the dialysis population
and all were on self care home dialysis. At the completion of the study 17
of the 25 patients were still alive; 2 with functioning transplants, 3 on
hemodialysis and 12 on CAPD. The duration on dialysis ranged from 8 to
71 months with a median of 35 months. Patient survival rates were
comparable with the national average at 12 months (90% vs. 89%) and 2
years (84% vs. 80%). During the study there were 8 deaths, 6 due to
cardiac causes, one due to multiple myeloma and one withdraw! from
therapy. Dialysis therapy was well tolerated and technique survival rates
were comparable for both hemodialysis and CAPD. At 12 months CAPD
technique survival rate was 80%, 70% at 2 years and 50% at 3 years. For
hemodialysis the technique survival rate was 83% at 12 months, 73% at 2
years and 36% at 3 years. The CAPD peritonitis rate was 1 in 28.5 patient
months. Self care home dialysis is a viable therapeutic option with a high
degree of compliance and good quality of life in the older population.
A survey of renal disease in a Northern Territory (NT) Australian
Aboriginal (AA) community. Wendy Hoy*, John Mathews, Robert McFar-
lane', David Pugsley2, Menzies School of Health Research and Royal Da,win
Hospital', Casuarina, NT 0811 and the Queen Elizabeth Hospital, Woodville,
SA 50112. We screened 262 adults (43% of the 1991 adult census) in a NT
AA community, to clarify rates and associations of the glomerulopathy
underlying their high rates of renal failure. Albumenuria was quantitated
by the albumen/creatinine ratio (ACR, gm/mole), with 3.4—33.9 (30—299
mg/gm) indicating microalbumenuria, and 34+ (300 mg/gm) indicating
overt albumenuria. Glucose tolerance (GT) was defined by WHO criteria.
BMI exceeded 25 kg/rn2 in 29.7% of subjects; 19.6% had type 2 diabetes,
and 10.7% had impaired GT (IGT); 18% of females and 38% of males had
SBP 140 and/or DBP 90 mm Hg. Fourteen subjects had leukocyturia,
and 4 had urinary infections. ACRs, similar in males and females, were as
follows:
<3.4 3.4—33.9 34+
Normal glucose tolerance (182) 56.0% 23.6% 20,8%
IGT and chemical diabetes (47) 36.1% 29.8% 34.0%
Clinical diabetes (33) 12.1% 18.2% 69.7%
Glucose tolerance was normal in 66% of subjects with microalbumenuria
and 49% of those with overt albumenuria. Blood pressures were normal in
81% of subjects with microalbumenuria and 51% with overt albumenuria.




35—54 years (48) 39.6% 31.3% 29.2%
55+ years (17) 11.8% 47.0% 41.2%
Serum creatinine was elevated in 6.9% of subjects (<106 mmole/L in
females, >120 in males), all with overt albumenuria. Idiopathic hematuria
1+ by dipstick was present in 6.5%, 10.2% and 20.6% of subjects in the
three ACR categories, or 12.9% overall. Subjects with multiple skin sores
had a 60% increase in hematuria (NS, P = 0.26), with no further increase
in the presence of group A streptococci, even those of nephritogenic M
types. Skin sores did not correlate with ACR. These data indicate high
rates to renal disease which is not consistently marked by hematuria and
is only variably complicated by hypertension; its expression increases with
age, and might be exacerbated by IGT and diabetes. Its aetiology,
pathogenesis and natural history are being pursued, and a treatment trial
is planned.
Plasma interleukin-6 and stress hormone responses to acute pyelone-
phritis. R.A. Donald, R.R. Bailey*, D,NJ. Hart, HI. Livesey, MJ. Evans, L.
Mattioli, J. Macdonald, AlL Smith, Departments of Endocrinology, Nephrol-
ogy and Immunology, Christchurch Hospital; Christchurch. This study was
undertaken to investigate the relationships between the "stress hormones"
corticotrophin (ACTH), vasopressin (AVP), corticotrophin releasing hor-
mone (CRH) and cortisol, and the cytokines, interleukin-i (IL-i), inter-
leukin-6 (IL-6) and tumour necrosis factor (TNF) in patients hospitalised
with acute pyelonephritis (fever> 38°C, loin pain or tenderness, infected
urine). Ten patients (7 female; age range 16—56 yr) with normal renal
function were studied. Peptide hormones were measured by RIA; cortisol
and cytokines by ELISA. Reference ranges were from samples donated by
40 volunteers from the electoral roll. Mean serum IL-6 and plasma AVP
and CRH concentrations on admission were significantly raised above
mean 0800 hr values for normal volunteers (P < 0.001), but mean plasma
ACI'H and cortisol were not. Mean IL-6 and AVP were more than 2 SD5
above the mean reference range for 72 hours, although IL-6 tended to fall
after 24 hr. No change in serum IL-I and TNF were observed in 3 patients.
The correlation between the IL-6 and cortisol concentrations at all
sampling times and in all subjects was highly significant (P < 0.001).
Significant correlation between serum IL-6 and AVP (P < 0.005) and IL-6
and ACTH (P < 0.05) were observed. No correlation between IL-6 and
CRH could be demonstrated. In summary, mean circulating levels of IL-6,
AVP and CRH were significantly raised in hospitalised patients with
severe acute pyelonephritis. Plasma concentrations of IL-6 correlated well
with the 'stress hormones' cortisol, ATH and AVP, but not CRH.
The influence of native and modified low density lipoproteins on normal
and diabetic rat glomerular core production of eicosanoids: The role of
phospholipase A2. N. Harley*, M Dunlop, G. Becker, R. Larkins, Depart-
ments of Medicine and Nephrology, University of Melbourne, The Royal
Melbourne Hospital; VIC. Hyperlipidaemia is associated with a variety of
renal diseases, particularly diabetic nephropathy, and experimental evi-
dence suggests a role for lipoproteins (LP) in its progression. The
influence of low density lipoproteins (LDL), unmodified and modified by
oxidation (OXLDL) or by glycation (GLCLDL), on prostaglandin £2
(PGE2) and thromboxane A2 (TxA2) production by mesangial cell
enriched glomerular cores (GC) and the contribution of cell associated
phospholipase A2 (PLA2) was investigated. Native and modified LDL was
prepared from human plasma. GCs were prepared by differential sieving
and collagenase digestion from control and Streptozocin (STZ)-injected
Sprague-Dawley rats with diabetes of 3 weeks duration. GCs were
incubated with the indicated LP for one hour. PGE2 and 'DA2 (as TxB2)
were assayed by specific radioimmunoassay and expressed as pg/iOO g
protein/hr. (t P < 0.05 ft P < 0.01 vs. non-diabetic control, * P < 0.05,
P < 0.01 vs. LP free).
control g/ml LDL OXLDL GLC LDL

































After incubation of the GCs for 30 minutes PLA2 activity was measured
in vitro by release of arachidonic acid from arachidonyl containing i4C
phosphatidylcholine, and activity expressed as nmol substrate hydrolysed/
min/.rg protein.
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control sg/ml LDL OXLDL GLC LDL
PLA2 4.52 0.72 100 5.53 0.69 8.94 0.69** 5.12 0.54
It is of particular relevance to diabetic nephropathy that LDL (specifically
OXLDL)-induced changes in PLA2 may be responsible in part for
alteration in prostaglandin and thromboxane production which in turn
may contribute to the altered glomerular haemodynamics implicated in
the progression of diabetic renal disease. [Data on PGE2 previously
presented ANZSN Hobart 1993]
Effects of growth hormone treatment on insulin-like growth factors and
their binding proteins in serum. S. Harrer*, M.J. van Renen, KF. Jureidini,
and A.A. Martin, Renal Unit, Women's and Children's Hospital and Child
Health Research Institute, 72 King William Road, North Adelaide, S.A. 5006.
It has been clearly demonstrated that growth retardation associated with
chronic renal failure (CRF) is significantly alleviated by administration of
recombinant human growth hormone (rhGH). The mechanisms of the
failure in CRF are not yet fully understood, but increased serum concen-
trations of insulin-like growth factor binding proteins (IGFBPs) may be
involved. The current study involves the analysis of the serum of 9 boys
with CRF (aged 4.6—13 years) treated with rhGH (30 IU/m2/week). We
have employed fast protein liquid chromatography (FPLC) under neutral
conditions in order to compare the IGF binding protein profiles at stages
throughout the treatment period within the same person, and in compar-
ison with normal age- and sex-matched children. Prior to assay of IGF-I
and -II by radioimmuno- and radioreceptor assay respectively, the extrac-
tion of IGFs was achieved with the use of high performance liquid
chromatography (HPLC) under acidic conditions. Serum was also assayed
for IGFBP-1, IGFBP-2, and the acid-labile subunit (ALS) by radioimmu-
noassay. FPLC profiles demonstrated increased IGF-I binding in the 50-30
kDa binding protein region in the serum of CRF children. IGF-I and -II
levels in serum rose by 160% and 40% respectively after 12 months of
rhGH treatment. At the same time, IGFBP-3 concentrations rose by 97%,
while IGFBP-1 fell by 35%. Levels of IGFBP-3 and ALS were strongly
correlated throughout the treatment period (P < 0.01).This study showed
abnormal IGFBP profiles in the serum of children with CRF. rhGH
treatment resulted in greater proportional increases in IGF-I than of
IGFBP-3, while IGFBP-1 levels fell, suggesting that the efficacy of rhGH
in overcoming the growth retardation is, at least in part, due to a relative
reduction in IGF binding capacity in serum.
Acute effect of ethanol on rat renal electrolyte transport. S.L. Carney*,
A.H.B. Gillies, CD. Ray, Discipline of Medicine, University of Newcastle,
NSW, 2308. The direct effect of ethanol on renal water and electrolyte
transport is poorly understood despite its widespread use as a recreational
drug. In particular data on the acute diuretic effect is contradictoiy and the
less well known antidiuretic effect has not been evaluated. Data on
electrolyte transport is sparse and also contradictory. Therefore the acute
effect of increasing plasma concentrations of ethanol was evaluated in
water diuretic anaesthetized rats which inhibits endogenous AVP release.
Ethanol at a plasma concentration of 1.69 0.28 mmol/L produced an
immediate increase in urine flow (174 11 to 189 13 and 206 12
jrL/min; P < 0.01) as well as an increase in fractional sodium excretion
(0.17 0.04 to 0.28 0.05 and 0.27 0.05%; P < 0.01).There was also
a brief phosphaturia. These increases in electrolyte excretion had returned
no control values by 20 minutes despite a further increase in the plasma
ethanol concentration. The urinary excretion of potassium, calcium and
magnesium was not altered nor was glomerular filtration rate or renal
plasma flow. Ethanol at a mean concentration of 3.21 mmol/L did not alter
the action of a maximal concentration of AVP (75 ng/kg) on water or
electrolyte transport. However, the antidiuretic effect of a submaximal
concentration of AVP (7.5 ng/kg) was augmented by ethanol. These
studies suggest that the ethanol induced diuresis commonly described to
inhibition of AVP secretion may also be due to other intrarenal effects of
ethanol, possibly acting within the proximal tubule. These results also
confirm recent in vitro findings that while ethanol does not inhibit the
action of a maximal concentration of AVP, it does modulate the effects of
lower AVP concentrations and possibly also distal water transport in the
absence of AVP.
A stereological analysis of the developing rat metanephros. IF. Ber-
tram *, K Spencer and GB. Ryan, Department ofAnatomy and Cell Biology,
University of Melbourne, Parkville, Vic, 3052. The development of the
permanent kidney, or metanephros, is a complex process. An objective,
morphometric description of metanephric architecture should prove use-
ful in identifying the role of specific growth factors in metanephric
development. In the present study, stereological methods were used to
estimate the absolute volumes of seven compartments in the developing
rat metanephros at embryonic days 15 (E15), E17, E19 and E21. Meta-
nephroi from Sprague-Dawley rats were embedded whole in glycol-
methacrylate, exhaustively sectioned at 2 sm, and stained with PAS. The
left metanephroi of three embryos from each of three mothers were
analysed at each of the four ages (a total of 36 kidneys). Volume densities
obtained using point counting were multiplied by total metanephric
volume (obtained using the Cavalieri principle) to estimate absolute






Mesenchyme 0.0782 0.0329 0.776 0.184 3.965 0.668 6.266 1.048
Ureteric 0.0071 0.0032 0.110 0.026 0.749 0.118 1.233 0.103
epithelium




S-shaped 0 0.059 0.036 0.345 0.060 0.426 0.070
bodies
Glomeruli 0 0.015 0.011 0.388 0.077 0.671 0.073
Tubules 0 0.030 0.020 1.635 0.276 3.627 0.585
Other 0 0 0.105 0.065 0.128 0.056
These data provide a baseline for future studies on the role of specific
molecules in renal development.
133Cs NMR evidence for tissue potassium compartmentation. R.M.
Wellard*, W.R. Adam, B.P. Shehan, # D.J. Craik#, Heidelberg Repatriation
Hospital Heidelberg West, Victoria 3089, Australia; #Victorian College of
Pharmacy, Monash University, Parkville Victoria 3052, Australia. This study
uses the NMR sensitivity of caesium as a congener of potassium to provide
further evidence for intracellular compartmentation of tissue potassium.
Following a caesium supplemented diet tissue caesium levels of 62.7 7.4,
74.2 2.9, 19.9 5.0 6.4 2.4and 0.66 0.26 imol/g were achieved for
liver, muscle, brain, erythrocytes and plasma respectively. While potas-
sium NMR spectra of both liver and muscle show single component
spectra, caesium spectra of liver at 65.60 MHz show the presence of two
components the separation being up to 0.8 ppm, suggesting the presence
of two pools of potassium in liver which are in slow exchange on the NMR
time scale. In muscle there was a single peak. This could be due to the
absence of distinct pools of potassium in slow exchange or a low
proportion of all but one potassium environment. Mitochondria are a
possible site for potassium to experience a different environment. NMR
spectra of isolated liver mitochondria are also non Lorentzian with two
peaks separated by 2.3 ppm. The two peaks seen for mitochondria are
probably from the mitochondrial matrix space and the medium, as
determined by shift reagent Dy(1THA)3. The distribution of caesium in
the two mitochondrial compartments also changes with time. The peak
attributed to matrix space changes from an initial 50% of total mitochon-
drial caesium to 15% after 6 h. These results add to the evidence for
compartmentation of caesium, and thereby potassium, in the cell and show
that NMR can be used to show dynamic changes in tissue electrolyte
content.
Systemic infusion of vasoactive intestinal peptide (VIP) impairs re-
sponse to a volume load. MA. Lonergan*, S. Aglibut and M.J. Field,
Department of Medicine, University of Sydney, Concord Hospital NSW2139,
Australia. An impaired renal excretory response to a volume load occurs in
cirrhosis. As elevated systemic plasma levels of VIP, due to decreased
hepatic metabolism, have been proposed to contribute to the generalised
systemic vasodilation that occurs in cirrhosis and result in sodium and
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water retention, we conducted clearance studies in normal Sprague-
Dawley rats to examine the effect of elevated plasma levels of VIP on the
renal response to a volume load. Animals were studied under mactin
anaesthesia. Ringer's solution was infused at 1% of body weight/h
following a priming injection of 1%. After an equilibrium period, two
baseline clearance periods (20 mm each) were performed, following which
the Ringer's solution was increased to 4% body weight/h for four
clearance periods. During the volume load VIP was infused at 0.1
nmol/100 g/hour. The Ringer's was then reduced back to 1% body
weight/h for a further two clearance periods. Time Control animals (TC)
received the Ringer's solution alone. Tritiated inulin and "C p-aminohip-
puric acid were included in the infused fluids to permit calculation of
GFR, fractional electrolyte excretion rates, renal plasma flow (RPF) and
filtration fraction (FF). Student's t-test was used to compare results
between groups and paired t-test the delta response. Blood pressure fell
significantly during the VIP infusion (15.6 3.9 mm Hg) despite the
concurrent infusion of a volume load. BP did not change significantly in
the TC group (2.3 4.7 mm Hg). Both GFR and RPF fell acutely with
commencement of the VIP infusion but then returned to control values.
FF was unchanged. Fractional (FENa) and absolute excretion (UNaV) of
sodium increased significantly compared to baseline for both groups;
however the response of the VIP group remained less than the TC group
(UNaV VIP 5.8 1.4 and TC 9.0 0.8 tmol/min per 100 g). Flow also
increased over baseline but the VIP group remained significantly less than
TC. VIP therefore impairs the response to a saline load in normal animals.
This is mediated in part by a fall in systemic blood pressure. These
haemodynamic and renal changes are similar to those that occur in
cirrhosis. These data thus support the view that VIP may be involved in the
altered sodium and water homeostasis that occurs in cirrhosis.
Low protein diet on the long-term effects of warm ischaemic renal
injury in the rat. P. Jablonskil*, D. Lau', V.C. Marshall', A. Stein-Oakley2,
N.M. Thomson2, Dept. of Su,ge.'y', Monash Medical Centre, and Dept. of
Medicine2, Alfred Hospital, Monash University. Low protein diets have been
used in patients with chronic renal disease. This study investigates the
effect of dietary protein on the progression of renal failure after warm
ischaemic injury (WI) in a rat model. WI was produced in male adult
inbred Dark Agouti rats (220—300G) by clamping left renal artery, vein
and ureter for 90 or 120 minutes and right nephrectomy (Nx) 3 days later.
Rats, fed either normal protein (NP = 20% protein, standard pellets,
Barastoc) or low protein (LP = 8% protein, an isocaloric pelleted
synthetic diet), were followed for 30, 90 or 180 days. All rats survived WI
and Nx with initial weight loss. Both diet groups regained weight at a
similar rate. Plasma creatinine was significantly (P < 0.05) higher in LP
rats from Day 8—90. Creatinine clearance was impaired in both LP and NP
rats; the impairment was greater in LP rats. Compensatory renal hyper-
trophy (NP = 75 + 7, LP = 48 + 12% at 180 days) was also significantly
impaired in LP compared to NP. Creatinine clearance per gram kidney
was similar to control values in all NP and LP rats and there was no
difference in interstitial fibrosis between LP and NP kidneys. After 180
days, NP rats showed increased proteinuria compared to LP rats (NP = 49
+ 3, LP = 22 + 4 mg/day) but this was within normal limits (25 to 55
mg/day). Cortex and medulla had a significant leucocyte infiltration which
diminished with time. After 180 days, the infiltrate was significantly lower
in LP kidneys compared to NP kidneys (medulla: NP = 1500 + 30, LP =
1060 + 50 and cortex: NP = 760 + 60, LP = 520 + 50 cells/mm2).
Conclusion: The possible benefits of LP in reducing proteinuria and
leucocyte infiltration were outweighed by impairment of compensatory
functional renal hypertrophy.
Mechanisms of iron (FE) tubulotoxicity in proteinuric chronic renal
failure (CRF). D.C.H. Ha,ris, J. Chen, L. Chen, B. Nanki veil, and Y-C. Tay,
Dept. Renal Medicine, Westmead Hospital, NSW 2145. Lysosomal FE
correlates with proteinuria and best predicts tubular damage in the rat
remnant kidney (RK) model of CRF. To investigate mechanisms of
FE-tubulotoxicity the effect of FE-loading on lipid peroxidation (malon-
dialdehyde, MDA), lysosomal (N-acetyl glucosaminidase, NAG; acid
phosphatase, AP) and mitochondrial enzyme activity and stability (enzyme
release), FE-reactivity and structural and functional damage was assessed
in proximal tubular cell culture (PTCC) and/or subcellular fractions of
normal (N) and 4—8 wk RK. Cytotoxicity in PTCC was assessed by tiypan
blue exclusion, LDH leakage and morphology. In PTCC cytotoxicity of
nitrilotriacetate (NTA)-FE was dose (50 .M) and time hr)-
dependent. The EC5O was 400 .LM NTA-FE at 24 hrs. Toxicity of
transferrin-FE will be examined. Acute and chronic (4 wk) in vivo
NTA-FE loading increased MDA in cortical cytosolic and lysosomal/
mitochondrial subfractions of RK and N (e.g. RK, cytosolic: 1.3 0.2 vs.
2.4 0.03 nmol/mg protein, sa; P < 0.01). At the stage when RK
tubular cell damage was evident by electron microscopy, NAG and AP
activities were higher in RK than N (P < 0.001), and NAG activity was
increased further by NTA-FE. Lysosomal fragility of RK and N were
similar, and were decreased by NTA-FE. Mitochondrial enzyme activity
was lower in RK than N, and NTA-FE had a variable and no effect
respectively on mitochondrial enzyme activity and fragility. Thus, impaired
function and increased fragility of lysosonies and mitochondria are
unlikely mediators of early FE-induced renal damage. FE-tubulotoxicity in
proteinuric CRF be mediated by lipid peroxidation.
Changes in tGFBPs in children with chronic renal failure, rhGH
treatment and transplantation. M.J. van Renen, S. Harrer, A.A. Martin, and
KF. Jureidini Renal Unit, Women's and Children's Hospital, and Child
Health Research Institute, 72 King William Road, North Adelaide, South
Australia, 5006. Three prepubertal children with severe chronic renal
failure (CRF) and short stature were treated with recombinant human
growth hormone (rhGH), at 30 IU/m2/week for 2 years, each receiving a
renal transplant early in the second year. Serum collected before and
during therapy was analysed for insulin-like binding proteins (IGFBPs) by
Western ligand (WLB) and immunoblotting techniques, and radioimmu-
noassay (RIA) for IGFBP-3, acid-labile subunit (ALS) and IGFBP-1. Age
and sex-matched normal serum was used as control. Ligand binding was
noted on WLB at 44—48, 34, 28, and 24 kDa and was identified as an
IGFBP-3 doublet, IGFBP-2, IGFBP-1 and IGFBP-4 respectively by
immunoblotting. A fainter protein band at 30 kDa was seen on WLB and
identified as IGFBP-3 by immunoblotting. This band was also present on
immunoblot in the normal controls but was not clearly seen on the WLB.
IGFBP-1, not apparently present on immunoblotting in control serum,
showed as a dense band in the CRF patients. This band disappeared after
transplantation. IGFBP-2 was seen, on WLB, as a more intense band in
CRF children prior to transplantation than in the normal controls. This
band also virtually disappeared following transplantation. In the first year
on rhGH treatment, mean IGFBP-3, by RIA, increased from 3.2 to 7.0
jg/ml and mean ALS from 18.4 to 41.6 ig/ml, while mean IGFBP-1
decreased slightly from 497 to 428 ng/ml. Following transplantation, mean
IGFBP-3 decreased to 4.8 tg/ml, however mean ALS remained elevated
at 45.2 j.g/ml. Mean IGFBP-1 fell further to 97.2 ng/ml. This study shows
that rhGH treatment in CRF results in significant increases in serum
levels, by RIA, of IGFBP-3 and of ALS, but not of IGFBP-1. There appear
to be forms of IGFBPs present in whole serum which do not bind well to
the radio-ligand during WLB, and immunoblotting may be necessary to
supplement this technique for IGFBP identification. The reduction in
IGFBPs following transplantation suggests correction of impaired clear-
ance by the diseased kidney.
A naturally occurring xenoantibody, anti-Gal, recognises epitopes in
pig kidney, heart and liver and is functionally active: Relevance to
xenotransplantation. M. Tange, A.M Fournier, I.E. Birchall, M Romanella,
A. Aminian, A. G. Kyriazis, M.J. Pearse, W.R. Adam, and A.J.F. d'Apice,
Dept. of Clinical Immunology, St. Vincent's Hospital, Fiztroy, Melbourne,
Australia, 3065 and Dept. of Pathology Univ. of Melbourne, Dept. of Renal
Medicine, Repatriation Hospital, Heidelberg. Human naturally occurring
antibodies against xenoantigens are the primary effective cause of hyper-
acute rejection. There is anti-galactosyl galactose antibody (anti-Gal)
specific for Gal alpha 1,3 Gal beta 1,4 GIcNAc in humans but not in pigs
due to the absence of the enzyme alpha 1,3 galactosyl transferase in
humans. We have found Gal epitopes in pig renal cortex, heart and liver
by indirect immunofluorescence and immunoperoxidase staining. Anti-
Gal strongly stained endothelial cells of glomerular capillaries, arteries,
and veins in porcine organs. The specificity of binding was demonstrated
by inhibition with terminal alpha 1 galactosyl carbohydrates such as
melibiose (Gal alpha 1,6 Glc) which reduced the staining to near
background. The functional role of anti-Gal was assessed. Porcine aortic
endothelial cells, labelled with 51Cr, in the presence of rabbit complement,
were lysed by heat inactivated normal human serum, or by the anti-Gal
component of human serum purified by affinity chromatography on a
galactosyl-galactose (Synsorb 115) affinity column. The 1gM fraction of
anti-Gal was responsible for lysis. Agglutination of 0.5% pig erythrocytes
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by pooled normal human AB serum can be inhibited by terminal alpha 1
galactosyl sugars. Human serum induced lysis of pig aortic endothelial
cells can also be inhibited only by terminal alpha 1 galactosyl sugars. In an
ex vivo model of hyperacute rejection, when a rat heart is perfused with
normal human plasma there is prolongation of time to hyperacute
rejection when terminal alpha 1 galactosyl sugars are perfused with the
plasma. In conclusion, Anti-Gal binds to alpha 1 Gal epitopes on porcine
endothelium, has a functional role in an ex vivo model of xenograft
rejection and is inhibitable by specific sugars.
Increased expression of transforming growth factor l3 (TGFp5) in a
model of chronic renal allograft rejection. A.N. Stein-Oakley, A. Tzanidis,
P.J. Fuller, P. Jablonski, and N.M. Thomson, Department of Medicine,
Monash Medical Schoo4 Alfred Hospital, Prahran, 3181; Monash Depart-
ment of Sutgeiy, MMC; Prince Henry's Institute of Medical Research;
Melbourne, Australia. TGF(31 has widespread effects on extracellular
matrix (ECM) and modulates proliferation of many cell populations
including mesangial cells and fibroblasts. TGFI31 stimulates its own
production as well as that of other cytokines such as PDGF and IL-i.
Chronic rejection (CR) is responsible for the loss of 50% of the renal
grafts after the first year. The deposition of collagen and other ECM
components and the proliferation of fibroblasts, resulting in damage
characteristic of CR, are consistent with a possible involvement of TGFI31.
This study describes the expression of TGF!31 in a rat model of CR.
Studies were performed on transplanted kidneys from tolerised AS
recipients of DA allografts at 5 days (N = 3), 1 (N = 5) and 3 (N = 9)
months post transplantation. Grafts at 1 and 3 months demonstrated
progressively more severe features of CR. Controls were kidney samples
from 4 normal rats (NRK), 6 isograft recipients (ISO) and 4 uninephrec-
tomized (U) rats killed 3 months post surgery. TGFI3I gene expression was
evaluated by Northern blot analysis of total RNA using a rat TGFI31
cDNA probe. RNA levels were standardised against GAPDH expression.
Densitometric analysis revealed 3.8, 4.2 and 2.6 fold increases in TGF!31
expression in the CR model at 5d, 1 (P < 0.05) and 3 (P <0.01) months
respectively versus NRK. Increased TGF!31 expression in CR suggests it
may be involved in the development of chronic damage. Both transcripts
of TGF13I mRNA (2.5 and 1.9 kb) were expressed in the CR model. The
ratio of the 2.5 kb/1.9 kb transcripts was lower in the CR model [5.4 0.5
(mean sEM) and 4.6 0.6 (P < 0.05) at 1 and 3 months respectively]
than in NRK (8.9 1.2). This is consistent with previous findings in
infarcted rat heart suggesting that the regulation of the 1.9 kb transcript
may be related to injury. TGF$31 expression in U kidneys did not differ
from NRK. Surprisingly, TGFI3I expression in ISO was increased 3.9-fold
(P < 0.05) versus NRK although ISO showed only minor chronic changes.
Thus increased TGF/31 expression may represent a response to transplant
injury. However, there could be differences in the activation state of
TGFI3I (latent or activated) in CR versus ISO, or a different relative
balance of TGFI31 and other cytokines in the tissue.
Enalapril controls post-transplant erythrocytosis by suppression of
erythropoietin production. KG. Wong, N. Bandler, P. G. Kerr, and R. C.
Atkins, Department of Nephrology, Monash Medical Centre, Clayton Vic
3168. Eiythrocytosis is a common finding in renal transplantation. The
aetiology may be multifactorial; including an increased production of
Erythropoietin (EPO). Clinical studies using Angiotensin Converting
Enzyme (ACE) inhibitors to treat post-transplant erythrocytosis (PTE)
have predictably demonstrated its haematocrit (Hct) lowering effect but
the data on changes in EPO levels are inconsistent. We therefore studied
the effect of ACE inhibition on serum EPO levels and its potential benefit
in controlling PTE. We treated 15 renal transplant patients (14 Mu F),
mean age 51.1 11.6 (range 23—64 yrs) who had a persistent Hct of 51%
or greater with Enalapril. Twelve patients had venesection before enroll-
ing in the study. Baseline measurements of Hct, creatinine clearance and
serum EPO levels were made before Enalapril therapy. Enalapril was
started at 2.5 to 5 mg daily and the dose was adjusted as necessary for
blood pressure control. The patients were followed at 1—2 monthly
intervals with repeat Hct, creatinine clearance and serum EPO measure-
ments. The mean Hct fell from 52.8 1.7 to 43.7 3.4 (P = 0.001) and
serum EPO fell from 24.1 21.0 to 7.5 6.8 mU/mI (P = 0.018) after 2
to 6 months of Enalapril therapy. The mean blood pressure, serum
potassium and creatinine clearance did not change significantly during
follow up. It is concluded that Enalapri! is safe and effective in controlling
PTE by suppression of EPO production.
Hyperlipidaemia and the response to simvastatin in renal transplant
recipients. C.S. Ong, CA. Pollock R.J. Caterson, D.A. Waugh, J.F. Mahony,
and L.S. Ibels, Department of Renal Medicine Royal North Shore Hospital,
St Leonards, 2065, Australia. A seven year prospective study assessing the
lipid profiles of 192 patients with functioning renal transplants, their
aetiological associations and response to therapy, in particular simvastatin,
was undertaken. The files of patients entered into the study were also
reviewed for retrospective data regarding their lipid profile. The mean
time from transplantation to last follow up was 103 4.8 (range 1—240)
months. 7.8% had diabetic nephropathy as a primary diagnosis. A
significant rise in serum cholesterol occurred 1—3 months after successful
engraftment, stabilising over the next 3 years, at which time hypercholes-
terolaemia was present in 71.3% of patients. There were independent
associations of serum cholesterol with prednisone dosage (P < 0.05), renal
dysfunction (P < 0.05) and smoking (P < 0.05) in the early post transplant
period. Those patients whose immunosuppression included cyclosporin
had lower serum cholesterol levels than those receiving azathioprine and
prednisone (P < 0.02).The presence of diabetes mellitus, hypertension or
the form and duration of prior dialysis did not independently influence the
lipid profiles. During the period of study 22 patients (11.5%) died, 54.5%
due to vascular causes. Those who died a vascular death had higher serum
cholesterol levels than those who died of other causes, which reached
statistical significance at 3 years post transplant (7.7 0.4 vs. 5.5 03
mmol/l; P < 0.02). No differences in the HDL subfraction nor in serum
triglycerides were observed in those who died of vascular causes. Cho-
lestyramine was introduced in 30 patients, only 2 of whom continued with
therapy beyond 3 months. Simvastatin was used in 43 patients, 20 of whom
were receiving cyclosporin, resulting in a reduction in serum cholesterol of
16.5%, from 7.0 0.2 to 5.7 0.1 mmol/l (P < 0.001) and in serum
triglycerides of 21%, from 2.9 0.4 to 2.3 0.3 mmol/l (P < 0.05). No
evidence of muscle, liver or renal toxicity occurred in 15.4 0.9 months of
follow up. We conclude that lipid abnormalities contribute to the high
vascular mortality in renal transplant recipients and simvastatin is a safe
and effective means of improving the lipid profile.
The role of eosinophils in acute renal allograft rejection. Wang Hong-
wei, R.S. Nanra, Anne Stein, Leanne Avis, Anna Price, and A.D. Hibberd,
Nephrology, Transplantation and Anatomical Pathology Units, John Hunter
Hospital, Newcastle, NSW, 2305. Tissue eosinophils (EOSs) have been
previously implicated in allograft rejection and graft loss. A retrospective
cohort study was undertaken to evaluate the role of EOSs in acute renal
allograft rejection. Tissue EOS density was measured morphometrically.
Data from 71 patients with 114 renal biopsies with acute allograft rejection
were compared with that from 26 controls. The median tissue EOS density
(0.4—1.1 EOSs/m2 X 106 and the median peripheral blood EOS (1.5—
3.0%) in all grades of acute interstitial rejection and in acute vascular
rejection were higher than that in controls (0.0 EOSs/m2 X 10, p <
0.0023, and 0.9%, P < 0.035, respectively). In all grades of rejection,
36—54% of biopsies had tissue EOS density 1 EOS4tm2 X 106, and
20—36% of patients had peripheral blood EOS 4%, compared to 0% and
4%, respectively, in controls (P < 0.000 and P 0.0245). The sensitivity,
specificity and overall accuracy of predicting acute rejection with tissue
EOS density i EOS/.Lm2 x 10 is 41%, 100% and 52%, and for
peripheral blood EOS 4% is 23%, 96% and 40%, respectively. The
median tissue EOS density in acute rejection with graft loss was 1.9
EOSs/m2 X i0 compared to 0.2 EOSs4rm2 x 10 in acute rejection
without graft loss (P = 0.014), and 67% of acute rejection with graft loss
had tissue EOS density 1 EOS/1.m2 X 10 compared to 28% of acute
rejection without graft loss (P = 0.028). It is concluded that (1) peripheral
blood EOS and increased tissue EOS density occur in up to 50% of
patients with acute renal allograft rejection, (2) these may be regarded as
diagnostic and prognostic markers of acute rejection, and (3) the eosino-
philic response may represent a secondary or nonclassical pathway of
allograft damage.
The association of acute leukaemia with the use of chlorambucil
following renal transplantation. W.K W. Ho, MR. Robertson, G.J. Mac-
donald, LA. Charlesworth, and BA. Pussell, Dept. of Nephrology, Prince
Henry Hospital and University of New South Wales, Sydney, NSW 2036
Australia. An increased incidence of neoplasms has been recognised
following renal transplantation. Although these have been predominantly
squamous cell carcinomas of skin, lymphomas and some mesenchymal
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tumours have been reported. Acute leukaemia has been reported follow-
ing the successful treatment of Hodgkin's disease and breast cancer,
especially with the use of alkylating agents. Because of these findings and
the recent reports of the use of chiorambucil in the treatment of
membranous glomerulonephritis we analysed, retrospectively, the use of
different immunosuppressive agents post renal transplantation in our unit
from 1.1.65 to 31.12.88. Data was obtained from the hospital records and
the Australian and New Zealand Dialysis and Transplant Registry. Three
hundred forty-eight patients on treatment for more than three months
were assessed. Two hundred twenty-three received azathioprine alone, 90
cyclosporin A azathioprine and 35 chlorambucil. All received cortico-
steroids and 92 received anti-lymphocyte preparations in addition to the
other agents. A total of 12 patients developed leukaemia. None of these
had received immunosuppressive drugs pre-transplant and all but one was
a primary renal graft. The type of leukaemia in each case was acute
non-lymphocytic and all developed the leukaemia after at least 11 months
of treatment. Nine patients had been treated with chlorambucil, 2 with
azathioprine only and 1 with cyclosporin A azathioprine. The associa-
tion between chiorambucil exposure and development of leukaemia was
highly significant ( = 52.93; P < 0.0001). In addition, within the
chlorambucil treated patients there was a relationship between total dose
of chlorambucil and development of leukaemia (mean 5537 mg versus
3138 mg; t =
—2.59; P < 0.02). Of 71 patients who received anti-thymocyte
preparations, 2 developed leukaemia and these 2 had also received
chiorambucil. None of 21 patients treated with OKT3 developed leukae-
mia. The time from transplant to diagnosis of leukaemia ranged from
11—164 months (median 70) and from diagnosis to death was 8—259 days
(148). All patients died from the leukaemia. This highly significant
association between the use of chlorambucil and subsequent development
of acute leukaemia suggests caution in the use of this agent in renal
transplantation and may also have implications for the recent interest in its
use to treat diseases such as membranous glomerulonephritis.
Do ACE inhibitors prevent diabetic nephropathy by reducing glomer-
ular protein synthesis? MM Makarious, KA. Duggan, G.J. Macdonald,
and J.A. Charlesworth, Dept. of Nephrology, Prince Henry Hospital, Sydney,
NSW 2036, Australia. Systemic and glomerular hypertension are impli-
cated in the initiation and progression of nephropathy in clinical and
experimental diabetes. The choice of antihypertensive agent is controver-
sial. Angiotensin converting enzyme (ACE) inhibitors may confer benefits
in reducing albuminuria in excess of the degree of blood pressure control,
possibly by modulating the intrarenal renin angiotensin system. We
studied the effects of similar blood pressure control using enalapril (10
mg/kg/day) or verapamil (13 mg/kg/day) on glomerular angiotensin II
receptors, glomerular protein, creatinine clearance and proteinuria in the
spontaneously hypertensive rat (SHR) three months after induction of
diabetes by streptozotocin. Blood glucose was maintained at 8—10 mmol/l
by daily insulin injection and blood pressure at 105—120 mm Hg systolic in
both groups. Creatinine clearance was lower in enalapril (0.46 0.05
mi/mm; P < 0.001) and verapamil (0.55 0.06 ml/min; P < 0.03) groups
than control (0.77 0.06 mI/mm) while proteinuria was lower in the
enalapril group (E: 5.6 0.79, C: 11.4 1.50, V: 13.2 1.47 mg/24 hr; E
vs. C: P < 0.0025, E vs. V: P < 0.001). Glomerular Ang II receptors were
decreased in the verapamil group (1804 202 fmoles/mg protein)
compared with enalapril (3079 149, P < 0.001) and control (2763 345,
P < 0.01). Glomerular protein was least in the enalapril group (48 3.1
ng/glomerulus) and greatest in the verapamil group (84 9.8 ng/
glomerulus, P < 0.0025). We conclude that both antihypertensive regimes
are equally effective in lowering blood pressure and preventing hyperfil-
tration. However, treatment with ACE inhibitors significantly reduces
proteinuria. In addition, by reducing Ang II stimulated glomerular protein
synthesis they may play a role in preventing glomerular sclerosis.
The effect of intravenous ouabain on pressor responsiveness in healthy
volunteers. G.B. Pidgeon, A.M. Richards, M.G. Nicholls, R.R. Bailey, KL.
Lynn, L.K Lewis, and T.G. Yandle, Departments of Nephrology, Cardiology
and Endocrinology, Christchurch Hospital, Christchurch, New Zealand. To
assess the effects of ouabain on pressor and vasoactive hormone respon-
siveness, 10 healthy volunteers were pre-treated with ouabain (0.5 mg iv.
42 and 18 hrs before study) or placebo, prior to pressor challenge with
angiotensin II (Ang II) (2, 4 and 8 ng/kg/min for 30 minutes per dose) and
noradrenaline (NA) (5, 15 and 45 ng/kg/min for 15 minutes per dose) in
single-blind, randomised, placebo-controlled, cross-over studies. Blood
pressure and heart rate (HR) were recorded manually at 15-mm (Ang II)
and 5-mm (NA) intervals. Holter ECG monitoring was performed.
Vasoactive hormones were measured at baseline and during infusions,
There were no differences at baseline between the two study days
regarding plasma electrolytes, creatinine, mean arterial pressure (MAP)
or HR. Baseline pulse pressure, however, was significantly greater follow-
ing ouabain (47 4 mm Hg vs. 41 1 mm Hg) [mean SCM] (P < 0.05).
The mean maximum increments in MAP during Mg II and NA infusions
were 17.5 1.1 and 10.5 1.3mm Hg respectively following ouabain, and
19.2 1.3 and 10.4 1.5 mm Hg following placebo (NS). The mean HR
was lower during both infusion periods on the ouabain study day com-
pared to control (P < 0.05). Baroreceptor reflex sensitivity was un-
changed. Baseline plasma levels of Ang II, aldosterone, plasma renin
activity, atrial and brain natriuretic peptide, cyclic GMP, NA and adren-
aline, and achieved levels during the two infusions, were similar on the two
study days. We conclude that short-term ouabain administration does not
alter pressor responsiveness or plasma levels of vasoactive hormones in
healthy volunteers.
The role of C-type natriuretic peptide in control of renal function in the
sheep. Margaret B. Fraenke4 G.P. Aldred, N.A. Yates and J. G. McDougall,
Howard Florey Institute of Experimental Physiology and Medicine, University
of Melbourne, Parkville, Victoria, 3052. Three receptors for the atrial
natriuretic peptide family have been identified. The GC-B receptor is a
membrane bound guanylate cyclase receptor which appears to have C-type
natriuretic peptide (CNP) as its natural ligand. CNP was initially thought
to be confined to the central nervous system, but mRNA for both CNP and
GC-B has recently been identified in most body tissues, where they are
thought to be possibly involved in a vascular autocrine or paracrine
system. As a CNP bolus had been reported to cause an antinatriuresis,
without change in blood pressur&, we wished to see if mRNA levels for
the GC-B receptor varied with sodium status. A 461 bp fragment of eDNA
for the ovine GC-B receptor was cloned from ovine pituitary RNA using
reverse transcriptase-PCR. There was 90% nucleotide sequence identity
to the human GC-B receptor and 97% similarity at the amino acid level.
The eDNA fragment was used as a probe for northern analysis of mRNA
isolated separately from renal cortex and medulla of 6 Na loaded, 6 Na
depleted and 4 control sheep. Levels of mRNA for the receptors were
quantitated using laser densitometry and standardised to 13-actin expres-
sion. The level of mRNA for the GC-B receptor in the renal cortex was
significantly higher in sodium depleted animals (1.57 0.17, mean SCM)
than in sodium loaded (0.86 0.12) or control (0.84 0.18) animals (P
<0.05). To investigate the role of CNP in renal function in sheep, CNP
was infused into the renal artery of 4 uninephrectomised, conscious,
sodium replete merino ewes at a rate of 185 pg/hr for one hour. MAP fell
from 80 3 mm Hg during the control period to 72 2 mm Hg in the 15
mm period following the infusion (P < 0.01). There was no significant
effect on GFR, ERPF, urine flow rate, Na, K or Ca excretion, although the
animals responded to ANP (50 pg/hr) with the expected increase in Na
excretion (from 153 33 .tmol/min to a maximum of 456 43 imol/min).
In summary, we have shown that mRNA for the GC-B receptor is present
in sheep kidney, and levels increase approximately two-fold with Na
depletion. However we have been unable to detect any effect of CNP, its
proposed natural ligand, on renal function.
1. STINGO et. al.: (1992) Amer. J. Physiol. 262:H308—312
This work was supported by an institute grant from NH&MRC and a
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Expression and molecular characterisation of tissue factor in crescentic
glomerulonephritis. J.H. Erlich, PG. Tipping, J.A. Apostolopoulos, N.
Mackman, D.J. Luskotoff and SR. Holdsworth, Department of Medicine
Monash University, Clayton, Vic 3168 and Scripps Research Institute, La
Jolla, CA, USA, Augmented pro-coagulant activity (PCA) with the char-
acteristics of tissue factor (TF) has been demonstrated in a rabbit model
of crescentic glomerulonephritis (GN) in association with proteinuria,
prominent fibrin deposition, and macrophage influx. TF is currently
thought to be the major in vivo activator of coagulation. A membrane
glycoprotein with several N-linked glycosylation sites, TF is dependent on
the presence of phospholipids for activity. To confirm that glomerular
PCA was due to TF, a monoclonal anti-rabbit TF antibody was prepared
that totally inhibited glomerular PCA. TF expression was assessed at days
1,4,7, and 12 in a preimmunised rabbit model of anti-GBM crescentic GN
and in normal rabbits. TF functional activity was determined in a one stage
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prothrombin assay. TF molecular weight was determined by Western
blotting and subsequent immunodetection with a monoclonal antibody to
rabbit TF. TF mRNA was assessed by Northern blotting and in situ
hybridization with a cDNA to rabbit TF. TF activity was upregulated at
day 1 (208 70 an (P < 0.05)) cf normal (40 1670 au) and remained
elevated throughout. Glomerular TF antigen was not increased until day
4 (2.43 0.09 au (P < 0.045)) ci normal (1.69 0.24 au). Rabbit
glomerular TF antigen exhibited a higher molecular weight (Mw) than
standard rabbit brain TF. The Mw of glomerular TF on days 4, 7, and 12
of this disease (the days associated with prominent glomerular macro-
phage infiltration) showed higher Mw bands to those seen in normal
glomeruli. The Mw of glomerular TF on these days corresponds to that of
TF expressed by activated macrophages. The variation in TF Mw on
different days and between organs was shown to be due to variable
glycosylation. TF mRNA was demonstrated to be intraglomerular by in
situ hybridisation. Glomerular TF mRNA was not significantly increased
until day 4 (169.8 18.3 AU (P < 0.044)) cf normal (100 12.1 AU). In
this model of GN increased glomerular PCA is due to TF; increased TF
functional activity precedes increases in TF antigen and mRNA; and the
higher Mw of TF at day 4 is associated with macrophage influx. This
suggests macrophages are the most likely source of this Mw TF. The
dissociation of the increase in TF functional activity and antigen expres-
sion may be due to a change in the TF phospholipid association and/or the
presence of inhibitors. Alteration in TF glycosylation may in turn alter its
avidity for inhibitors.
Risk factors for acute pyelonephritis in preschool children. J.C. Craig
L.P. Roy, and J.F. Knigh4 Department of Nephrology, Royal Alexandra
Hospitalfor Children, Sydney, NSW, 2050. To determine the epidemiology,
microbiology, and natural history of the first symptomatic urinary tract
infection (UTI) in preschool children with no known predisposing condi-
tion, a prospective study of all eligible children presenting acutely to this
hospital has been established, and the frequency of acute pyelonephritis
(APN) and risk factors for this precursor of renal scarring have been
determined. To date, 125 children have been identified, primarily by
analysis of all urine samples sent to the microbiology department for
microscopy and culture. Patients were reviewed whilst in the acute phase
of the illness and all relevant clinical and microbiologic details were
recorded. The diagnosis of APN was made by dimercaptosuccinic acid
scan (DMSA). Abnormalities in the DMSA scan were graded from 1—4
(grade 1: 1 or 2 focal defects, grade 2: 3 or more focal defects, grade 3:
diffuse parenchymal abnormality >10% differential function, grade 4:
10% differential function), with the DMSA score defined as the sum of the
score of each of the 2 renal units. Of the 125 children with a proven UTI
presenting to this hospital, 121 (97%) have had a DMSA scan from 1—25
days after diagnosis (mean 7.7 days, sn 4.4 days). Thirty-four percent had
scan evidence of APN (41 patients, 52 renal units). One hundred
twenty-two patients (98%) had a renal ultrasound (USS) examination.
Vesicoureteric reflux (VUR) was present in 31% of 106 patients in whom
a micturating cystourethrogram (MCU) has been performed. VUR was
detected in only 59% of children with APN. The USS correctly detected
APN in 20%. All variables of epidemiology, clinical presentation, micro-
biology, ultrasound and MCU results were analysed as possible risk factors
for acute pyelonephritis (abnormal DMSA scan) using linear regression.
Only a history of previous unexplained fever (relative risk of 4.3 (95% CI
1.2—15.4, P = 0.027) and VUR (relative risk of 5.6 (95% CI 2.2—15.4, P =
0.0001) were found to be significant predictors of APN. These same
variables were analysed by logistic regression to determine independent
predictors of the DMSA score. VUR, intrarenal reflux (IRR), and calyceal
dilatation on ultrasound were all found to be highly predictive of the
DMSA score. We conclude that a history of unexplained fever and VUR
predict for APN, and VUR, IRR and calyceal dilatation predict for the
severity of APN. However, the sensitivity of the MCU in detecting
preschool children with APN is only 59%, therefore this test alone, or in
combination with the USS, does not detect acute parenchymal defects in
40% who may be at risk of permanent scarring.
Peritoneal dialysis solutions (PDS) inhibit human mesothelial cell
biosynthesis in vitro. S.D. Bird, F.M. Munro, and R.J. Walker, Medicine
Dept., Otago Medical School, Dunedin, NZ. Peritoneal dialysis solutions
(PDS) utilise high glucose concentrations (76—214 mM) for ultrafiltration.
Recent studies have suggested that PDS may be cytotoxic to mesothelial
cells. The initial peritoneal mesothelial cell (PMC) response to exposure
to PDS has not been well defined. Aims: to define the biosynthetic
response of human PMCs to PDS compared to an epithelial cell line
(LLC-PK). Human PMCs were obtained from omentum by enzymatic
digestion and grown in DME/F-12 media with 10% FCS. Cells were used
at passage 2. Confluent cells in 24 well plates were exposed to KR buffer
(glucose 5.5mM), 1.5% (76mM), 2.5% (126mM), 4.25% (214 mM) PDS for
2—8 hours. DNA and protein synthesis was measured by 3H-thymidine
(3HT) and 3H-leucine (3HL) incorporation (cpm/mg protein). Cell viabil-
ity was measured by trypan blue exclusion. Results are mean SCM N =
10—20. *P < 0.05.
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PDS were toxic to both cell lines with a significant reduction in viable cells
by 6 hours. DNA synthesis was significantly reduced as early as 2 hours in
PMC at all concentrations. Protein synthesis was similarly inhibited. PMC
were much slower to recover following re-exposure to normal culture
media. This is most likely an acute response to the high glucose concen-
trations. Experiments are currently underway to exclude pH or osmotic
effects. This would suggest alternative agents to glucose in PDS need to be
found.
Circulating renotropic factors and epithelial transport. C.A. Polloc/ç
M.S. Nobes, A.Z. Gyoy, P. T Heng and M.J. Field, Department of Medicine,
University of Sydney, Royal North Shore Hospital, St Leonards, 2065,
Australia. It has been postulated that circulating growth factors play a role
in the development of renal hypertrophy. In order to investigate the effect
of these factors on glomerular filtration and epithelial transport, mi-
cropuncture experiments were performed on normal 6—7 week old
Sprague Dawley rats infused with 20% plasma derived from rats in whom
nephrectomy had been performed 3 days previously; N = 4. Animals
infused with plasma from rats which had undergone sham nephrectomy
served as controls; N = 4. When animals infused with plasma from
nephrectomised animals (NxP) were compared with those infused with
control plasma (CP), the former had a higher tubular fluid flow rate
measured at both the late proximal (LP) (26.7 1.6 vs. 18.3 1.4 nI/mm;
P < 0.0005) and early distal (ED) (14.9 1.0 vs. 7.8 1.0 nI/mm; P <
0.0001) site, which was reflected in the final urine flow rate (16.1 3.4 vs.
5.1 0.8 jl/min; P < 0.005). The single nephron glomerular filtration rate
(SNGFR) was higher as determined at the LP (45.8 2.8 vs. 35.7 2.3
nl/min; P < 0.01) and ED (34.5 2.5 vs. 28.1 1.8 nI/mm; P = 0.05) site.
However, this increase was not reflected in the whole kidney GFR (1.04
0.06 vs. 0.89 0.06 mls/min/100 g; P = 0.07), suggestive of a preferential
increase in filtration in the outer cortical nephrons. Tubular Na transport
was higher in the animals infused with NxP, as evidenced by a decrease in
the fractional delivery of Na at the early distal site (4.5 0.4 vs. 6.5 0.4;
P < 0.02). However, in the final urine there was a significant increase in
the fractional sodium excretion in animals infused with Nx plasma (0.67
0.14 vs. 0.29 0.09%; P < 0.05) indicating that natriuresis and probably
diuresis was a result of inhibition of Na and water transport in the late
distal tubule and collecting duct. In conclusion these experiments demon-
strate that circulating factors induced by a reduction in renal mass
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significantly alter glomerular filtration and tubular Na transport. Although
the present experiments do not define the nature of these factors, it is
likely that they play a role in the subsequent development of compensatory
renal hypertrophy.
Detection of hydroxyl radicals following ischaemia and reperfusion in
isolated rat kidneys. M Kadkhodaee, Z.H. Endre, R.A. Towner, and M
Cross, Department of Medicine, University of Queensland, Royal Brisbane
Hospital, Qld 4029. The role of oxygen derived free radicals in acute renal
failure remains controversial. In order to quantitate hydroxyl radical
generation in vitro in isolated rat kidneys during hypoxia and during
reperfusion following ischaemia, salicylate was used as a chemical trap to
react with hydroxyl radicals to produce 2,5-dihydroxybenzoic acid
(DHBA) which could be detected by HPLC combined with electrochem-
ical detection (ED). Right kidneys from male Wistar rats perfused with
Krebs-Henseleit buffer (KHB) with 6.7% albumin. Perfusion pressure,
flow and oxygen tension were continuously monitored. Function was
monitored from the inulin clearance and sodium and potassium excretion.
Five groups (each N = 5)were studied: group 1 (normal control), perfused
for 75 mm; group 2 (salicylate control), supplemented with 0.5 mi's
salicylate; group 3 (ischaemia), salicylate plus ischaemia induced for 15
mm followed by 15 mm reperfusion; group 4 (DMTU-ischaemia), 15 mM
DMTU plus salicylate, before induction of ischaemia followed by reper-
fusion; group 5 (hypoxia), salicylate followed by 15 mm of hypoxic
perfusion. Under normoxic conditions in salicylate control kidneys (group
2), peaks corresponding to the hydroxyl radical were detected as 2,5-
DHBA. During ischaemia and reperfusion (group 3) there was more than
a two fold increase in production of hydroxyl radical (P < 0.001). Adding
15 mM DMTU before ischaemia (group 4) prevented the increase in
2,5-DHBA. Induction of 15 mm of hypoxia (without normoxic reperfu-
sion) impaired kidney function predictably (group 5) but did not increase
2,5-DHBA. This supports the recent observation that DMTU and DMSO
protect against hypoxic injuly by a mechanism independent of the binding
of free radicals. The increase of 2,5-DHBA in ischaemic-reperfused
kidneys, indicates hydroxyl radical formation which is supported by the
observation that pretreatment with DMTU prevented any increase in
2,5-DHBA. This is the first observation in vitro or in vivo of specific
hydroxyl radical generation following ischaemia-reperfusion in the intact
kidney.
1. CROSS, M., ENDRE, Z.H., STEWART-RICHARDSON, P. CowiN, GJ., ET
AL.: Magn. Reson. Med. 30:465—475, 1993.
Proximal tubular (PT) amphotericin B (AMB) toxicity: An electron
microprobe study. C.A. Pollock M. Dyne, Mi Field, N. Salipan Moore, S.
Reddy, D. Cockayne, and AZ. Gyoiy, Department of Medicine and Electron
Microscope Unit, University of Sydney, Royal North Shore Hospital St
Leonards, NSW, 2065. The renal toxicity of AMB clinically manifests
largely as distal tubular injury, with K wasting, renal tubular acidosis and
a reduction in GFR. The defect is presumed to be due to an increase in
permeability of Na, K and H ions in the tubular epithelium. As this toxicity
has been shown in vitro to uniformly affect the nephron, it is surprising that
more marked proximal tubular dysfunction is not observed. The following
experiments, on male Wistar rats, were designed to assess using electron
microprobe analysis (EMPX), the alterations in intracellular electrolyte
concentrations in proximal tubular cells as a result of AMB treatment.
Five animals were prepared as for micropuncture experiments and infused
with modified Ringers solution at 1.2 ml/100 g/hr. After equilibration, two
30 minute clearance collections were done. AMB was then infused at a
rate of 1 mg/kg/hr and after equilibration 2 further clearance collections
were made. At the conclusion of the clearance study isotonic RbCI was
infused at 0.5 mmol/kg over 30 sees, as a further marker of K transport,
and the kidney immediately removed. Controls were animals infused with
Ringers solution or AMB buffer alone. Clearance data confirmed a drop
in GFR in the AMB treated rats compared to control (0.69 0.11 vs. 1.27
0.08; P < 0.001). However, no difference in the urine flow or fractional
excretion of Na and K was evident. Measurement of intracellular electro-
lytes of PT cells in mmol/kg wet weight by EMP analysis demonstrated no
difference in Na (16.1 0.6 vs. 17.2 0.5) or K (129.7 2.1 vs. 131.3
2.0). However, a significant reduction in Cl occurred (12.7 0.4 vs. 14.1
0.4; P < 0.05). Intracellular Rb accumulation was significantly reduced
in the AMB treated animals (3,9 0.4 vs. 6,6 0.4; P < 0.0001)
suggestive of a reduction in basolateral Na-K ATPase activity. These
results do not support the tenet that AMB causes a generalised increase in
epithelial cell membrane permeability, nor direct cellular toxicity in the
doses studied. Rather they suggest that a primary reduction in GFR
results in a load-dependent decrease in proximal tubular Na transport.
Alterations in plasma ANP, BNP and cardiac volumes with changes in
intravascular volume in chronic renal failure. J.M. Corboy, R.J. Walker, M.
Simmonds, G. T. Wilkins, A.M. Richards, and E.A. Espiner, Medicine Dept.,
University of Otago Medical Schoo4 Dunedin, NZ. Atrial natriuretic peptide
(ANP) and brain natriuretic peptide (BNP) levels are elevated in condi-
tions of fluid overload including chronic renal failure (CRF). This study
was designed to investigate the changes in plasma ANP and BNP with
changes in atrial and ventricular volumes following alterations in intravas-
cular volume during hemodialysis. Eight patients (6 males) with chronic
renal failure (CRF) on haemodialysis, who were normotensive with no
heart disease were studied. Two phases in the study. 1. Ultrafiltration
(UF) (3% body weight) over 2 hours. 2. Volume repletion over 2 hours
plus an additional 0.51 saline. Weight (bed scales), blood pressure, heart
rate were recorded and venous samples (electrolytes and hormones) were
measured every 30 mins. Two-dimensional echocardiography was per-
formed at 0, 120, 240, 270 mins and chamber volumes calculated, Results:
Changes in plasma ANP during UF correlated significantly with changes
in LAy (r = 0.64). There was no significant correlation between BNP and
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Discussion. Baseline levels of ANP and BNP were elevated above normal
with a significant reduction in plasma ANP and BNP (minor) following
UF. The exaggerated release of ANP during volume repletion was not
paralleled by changes in BNP levels. Changes in BNP levels were small
with no correlation with atrial or ventricular volumes. This would suggest
that in CRF, ANP release is a more important factor in regulating acute
changes in intravascular volume. In CRF and normal myocardial function,
BNP appears to have only a minimal role in acute changes in intravascular
volume, despite elevate basal levels.
In vivo regional image-guided 1H-NMR spectroscopy of rat kidney. R.A.
Towner, Z.H Endre, S. Wilson, and D. Doddrell, The University of Queens-
land, Royal Brisbane Hospital and Centre for Magnetic Resonance, Brisbane,
QId. 4072 Australia. We present the first noninvasive study of in vivo
cortical and medullary image-guided proton NMR spectroscopy in rat
kidney. This technique was also used to monitor biochemical changes
during and after in vivo ischaemia-reperfusion injury. Image-guided,
microvolume, high resolution localized 'H-NMR spectra were obtained in
vivo at 4.2 T in kidneys of 150 g Wistar rats from 14—20 j.rl volumes (2.2 X
2.2 x 2.2 mm3 to 2.7 X 2.7 X 2.7 mm3) using the VOSY pulse sequence
with CHESS water suppression, an actively decoupled resonator/surface
coil assembly, a high strength (30 Gauss/cm) gradient set, and respiratory
gating. Spatial coordinates for the localized 1H-NMR spectra were
obtained from transverse 1H-NMR images (spin echo; TRTI'E 18/800 ms)
of anaesthetized rats (1.5% Isoflurane). The obtained microvolume
spectra allowed non-invasive in vivo differentiation of biochemical infor-
mation between cortex and medulla. The main biochemical differences
detected were much higher amounts of osmolytes, such as the trimethyl-
amines (TMA5; e.g., betaine), inositol and sorbitol in the renal medulla
than in the renal cortex. The same sequences were used to monitor renal
medulla before, during and after ischaemia-reperfusion. The right renal
artery was surgically exposed and fitted with an adjustable mechanical
occluder. Renal medullary 'H-NMR spectra showed that during 30 mm
ischaemia, lactate levels increased whereas sorbitol and TMAs decreased.
After reperfusion sorbitol and TMA levels increased within 15—30 mm,
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and lactate decreased to pre-ischaemic levels over 1—2 hours. This
technique appears to be suitable for differentiation of in vivo biochemical
information between the renal cortex and medulla, and for assessment of
in vivo renal ischaemia-reperfusion injuiy.
Mechanism of tubular uptake of filtered iron in rat remnant kidney
(RK). B.J. Nankivell, Y.C. Tay, R.A. Boadle, J. Chen, and D.C.H. Harris,
Dept. Renal Medicine and EM Unit, Westmead Hospital, NSW 2145. Iron
accumulates within proximal tubular lysosomes in human and experimen-
tal chronic renal failure. The mechanism of accumulation has not been
defined. The effect of iron-transferrin dissociation on tubular iron uptake
was determined in RK (N = 35)and sham-operated controls (SO, N = 16)
fed a NaHCO3- or NaCI-supplemented diet for 8 wks. NaCI-fed RK rats
had increased systolic blood pressure, final serum creatinine and de-
creased urinary pH. The substantial accumulation of iron, as demon-
strated by energy dispersive X-ray analysis (EDS) in RK (P < 0.01 vs. SO),
was not influenced by urinary pH, suggesting that dissociation of iron from
transferrin did not occur in the acidic tubular-lumen. The filtered protein
marker, horse-radish peroxidase (HRP, 6.25 mgJlOO g BW), was also
administered to RK and controls. Uptake of protein and iron by individual
tubules was determined by EM histochemistry and EDS, on tissue fixed 15
and 60 minutes after HRP injection. Iron was present with HRP in apical
lysosomes. After 15 minutes, HRP uptake correlated with numbers of
iron-containing lysosomes (r = 0.65, P < 0.01). At one hour, secondary
lysosomes (HRP-negative) contained less iron than recently reabsorbed,
HRP-positive lysosomes (P < 0.01), consistent with release of lysosomal
iron. Electron-dense focal accumulations of iron were demonstrated in
tubular cytoplasm (but not nucleus) at high-magnification, by EDS. These
data demonstrate in RK that filtered iron-transferrin can be reabsorbed
intact across the brush-border membrane into tubular lysosomes along
with bulk protein uptake, followed by release of iron and overload of
cytoplasmic stores.
Effect of cyclosporin on macrophage infiltration and cellular prolifer-
ation in the Thy-i.! model. Mary Polihronis, Brendan F. Murphy, and David
A. Power, Dept. Nephrology and Clinical Immunology, St. VIncent's Hospital,
VIC, 3065. Accumulation of glomerular extracellular matrix and prolifer-
ation of mesangial cells are important features of glomerulonephritis
(GN) that progresses to end-stage renal disease. A model of mesangial
proliferative GN can be induced with an antibody directed to the Thy-1.1
antigen on mesangial cells. Chemokines such as monocyte chemotactic
protein-i (MCP-1) and cytokines including platelet-derived growth factor
(PDGF) and transforming growth factor-13 (TGF-3) appear to be impor-
tant in the pathogenesis of this model. In this study, therefore, we
attempted to modify the Thy 1.1 model with Cyclosporin A, a cytokine
inhibitor. Glomerulonephritis was induced in two groups of rats by a single
intravenous injection of anti-thymocyte serum. One group of animals was
treated with CsA 10 mg/kg daily, the other served as a control. The rats
were sacrificed at various time points. Histologic examination of kidneys
biopsies revealed significant differences between the control and CsA
treated rats in the extent of macrophage infiltration and mesangial cell
proliferation. At day 3 there was a significantly (P < 0.01) greater influx of
ED-i positive cells (6.47 0.61) in untreated rats compared with
CsA-treated animals (2.33 0.61). Expression of a-smooth muscle actin,
which has been associated with mesangial cell proliferation in this model,
was also reduced in rats treated with CsA but there was no change in the
number of cells expressing PCNA, a marker of proliferating cells. These
results suggest that cyclosporin reduces the signals leading to macrophage
infiltration within the mesangium in the Thy 1.1 model. Secondly, there is
no direct relationship between mesangial cell proliferation and a-smooth
muscle expression, as has previously been reported.
Renal hypertrophy in two rat models of cirrhosis. MA. Lonergan, S.
Aglibut, and M.J. Field, Department of Medicine, University of Sydney,
Concord Hospital, NSW 2139, Australia. Avid proximal tubular sodium
retention occurs in cirrhosis. Renal hypertrophy occurs in other circum-
stances of increased tubular transport. During studies of possible media-
tors of the altered sodium and water homeostasis that occurs in cirrhosis,
we measured rat kidney weights to examine if alterations in renal mass
were seen in these models. Two models of cirrhosis were utilised, that of
carbon tetrachloride-induced cirrhosis (Cd4), and bile duct ligation and
resection (CBDL). Controls for the CCI4 model consisted of rats receiving
phenobarbitone alone and for the CBDL model, sham operated rats.
Clearance studies were performed under mactin anaesthesia after 16
weeks for CC!4 and 4—5 weeks for CBDL, following which animals were
bled for biochemical studies. Following exsanguination, the capsule of
each kidney was stripped and the renal pedicle cut flush with the hilum.
The kidneys were patted dry and weighed. In both models, the kidney
weights, both absolute and relative (per 100 g of bodyweight) were
significantly greater in the cirrhotic rats than in the controls (P < 0.001).
In the CC!4 model: the absolute weight of the right kidney of the Control
rats (N = 29)was 1.48 0.03 and of the CC!4 (N = 34) 1.66 0.04 grams;
relative weight of the Control was 0.306 0.004 and CC!4 0.409 0.013.
In the CBDL model: the absolute weight of the right kidney of the Sham
rats (N = 20) was 1.38 0.03 and of the CBDL (N 27) 1.52 0.03;
relative weight of the Shams was 0.33 0.009 and of the CBDL 0.46
0.013. The increased weight of the kidneys is consistent with renal
hypertrophy occurring in response to the avid proximal tubular sodium
reabsorption that occurs in cirrhosis. Although the changes in renal
function that occur in cirrhosis are due primarily to hormonal effects
resulting from the altered haemodynamics in this condition, the present
results suggest that there are also intrinsic (structural) changes induced in
the kidney that may contribute further to the altered tubular handling of
salt and water. These findings justify further studies into the morpholog-
ical basis of the hypertrophy, and into the possible mediating factors, such
as hepatocyte growth factor.
Mast cells (MC) and type VIII collagen in human diabetic nephropathy
(DN). B. Ruger, R. Dunbar, Q. Hasan, N. Greenhill, H. Sawada, and T.J.
Neale, Dept. of Medicine, Wellington School of Medicine, and Yokohama
City University, School of Medicine, Yokohama, Japan. Human MC are
increasingly associated with angiogenesis, chronic inflammation and fibro-
sis but are not known to produce extra cellular matrix (ECM) components.
Type VIII collagen is a non-fibrillar short chain collagen (also associated
with angiogenesis) that forms a molecular bridge connecting ECM
components. MC were identified in a number of tissues with monoclonal
antibodies specific for human tryptase, chymase, and c-kit and histochem-
ically with berberine sulphate, safranin and alcian blue. Many MC
expressed type VIII collagen by immunohistochemistry using antibody
specific for the a-i chain. MC did not express the interstitial collagens I,
III and V and pretreatment with collagenase abrogated type VIII collagen
staining but did not prevent staining for tryptase. We examined the
contribution of MC and type VIII collagen to the fibrosis occurring in DN.
MC were prominent in the interstitium in DN (N = 20) and were located
particularly perivascularly. Periglomerular fibres in DN stained intensely
for type VIII collagen. There was a correlation between the proportion of
MCTC cells and the percentage MC positive for type VIII collagen in DN.
RT-PCR identified the mRNA for type VIII collagen in kidney tissue.
Digoxigenin-labelled anti-sense probes specific for type VIII collagen
mRNA proved by in situ hybridisation that MC in the kidney produce type
VIII collagen. Sense probe and RNase pretreatment controls were
negative indicating specificity. MC proliferation and type VIII collagen
production in situ may be early events in fibrosis, that are later assisted or
completed by fibroblasts and their interstitial fibrillar collagen products.
Our finding that type VIII collagen is produced by human MC in fibrotic
tissues, particularly DN, provides the first evidence of a synthetic role for
MC in the construction of connective tissue in vivo.
Collagen type HI glomerulopathy: Extension beyond the glomerulus.
J.P. Dowling, I.K Forbes, and S. T Chou, Departments of Anatomical
Pathology and Nephrology, Royal Melbourne Hospital, Parkville 3050,
Victoria, and Pathology Repatriation Hospital, Heidelberg. An unusual form
of renal disease characterized by the mesangial, glomerular capillary loop
and, perhaps, tubular basement membrane accumulation of material
shown by immunohistochemistiy to Consist mostly of collagen type III has
been increasingly recognized in both adults and children. The ultrastruc-
tural features are similar to those of the nail-patella syndrome (N-PS). We
present a recent example of this rare lesion which developed in a 51 year
old female of mid-European origin who for several years prior to the
development of microscopic haematuria and mild proteinuria (0.6 gm/
day) had been treated for hypertension, hypercholesterolaemia and
peripheral vascular disease involving carotid and leg vessels. An intrave-
nous pyelogram was normal. Antinuclear antibody titre was 1:150 and
erythrocyte sedimentation rate 70 mm/hr. Serum creatinine at the time of
renal biopsy was 0.10 mMo!/l and she was receiving Enalapril. Renal
938 Abstracts
biopsy revealed striking mesangial acellular nodular expansion and capil-
lary wall thickening with mild glomerular hypercellularity and mild
tubulointerstitial damage with patchy thickening of tubular basement
membranes, all due to the accumulation of lightly eosinohilic amorphous
material. Immunohistochemistry showed irregular light to moderate 1gM
staining of capillary loops and mesangia and the amorphous material
stained strongly in all areas with an anti-collagen type HI antibody on
streptavidin-biotin immunohistochemistry. Severe intracranial disease and
cardiac failure with cardiac ariythmias developed and the patient died 20
months after renal biopsy. Autopsy findings revealed little if any progres-
sion in renal deposition of collagen III, atherosclerosis of aorta with
involvement of coronary, carotid and renal ostia and evidence of myocar-
dial and cerebral ischaemic damage. The renal lesion which may be part of
a generalized disturbance of collagen metabolism appears distinct from
NPS and is suggested by Gubler et al to have autosomal recessive as
opposed to the autosomal dominant inheritance in N-PS. This is the first
report to emphasize involvement of tubulointerstitial tissues in the
process.
1. GUBLER MC ET AL.: Pediatr. NephroL 1993, 7:354—360
Modulation of cytokine and fibronectin expression in an animal model
of focal glomerulosclerosis by a low protein diet. Brigitte Schiller and John
Moran, Dept. of Nephrology, Rush Presbyterian Medical Center, Chicago, IL,
USA; Renal Division, Baxter Healthcare, McGaw Park, IL, USA. We
investigated cytokine expression in the puromycin aminonucleoside(PAN) model of focal glomerulosclerosis (FGS) in two groups of rats fed
either a 24% (normal) or 6% (low) protein diet followed for 28 days.
Cytokine expression was evaluated by Northern blot of pooled RNA from
whole kidneys (3—5/group) hybridized with IL-i j3, TNF-n, TGF-J3, MCP-1
and fibronectin. Both PAN groups showed significant proteinuria from day
5, with a peak on day 10: (Mean SD) 679 37 (24%) vs. 417 63 mg/24
hours (6%). FOS was significantly less in the 6% group (7.5 1.2 vs. 20.7
3% of glomeruli, P < 0.05). TGF-3 expression was found to be only
slightly altered within the first 7 days in both PAN groups. However on day
10 a marked increase in both groups (2-fold in 6% group, 3-fold in 24%
group) was found, which progressively increased until day 28 (5-fold in
24% group, 2.5-fold in 6% group). MCP-1 showed in the 6% group an
immediate 6-fold increase on day 5, whereas the 24% results remained
similar to control values. On day 28 we found a 3-fold increase in the 6%
protein group, which was again lower in the 24% group at this time
(2-fold). IL-ip or TNF-a expression was not detected. Fibronectin
expression was more than 6-fold increased on day 28 in the PAN 24%
group, whereas the 6% group was close to control levels. Conclusion: A
low protein diet modulates the expression of MCP-1, TGF-/3 and fibronec-
tin in kidneys developing glomeruloscierosis after PAN injection. This
altered cytokine expression may explain the decreased FGS in rats on the
low protein diet.
Focal glomerulosclerosis in the remnant kidney model: An inflamma-
tory disease mediated by cytokines. Brigitte Schiller, Michael DeLeo, Emily
Warren, and John Moran, Dept. of Nephrology, Rush Presbyterian Medical
Center, Chicago, IL, USA; Renal Division, Baxter Healthcare, McGaw Park,
IL, USA. We investigated cytokine expression in 5/6 nephrectomized rats
fed a normal (24%) or low (6%) protein diet and compared to sham
operated rats on the same diets. The rats on 6% protein had less
proteinuria than the rats on 24% (Mean SEM: 2 weeks, 45.1 1.07 vs.
126.7 3.53; 4 weeks, 36,9 4.51 vs. 175.8 34.41 mg/24 h) and
significantly less focal glomerulosclerosis (FGS) (17.4 4.4 vs. 27.4
8.8% of glomeruli at 7 weeks). Cytokine expression was evaluated by
Northern blot of total pooled RNA extracted from whole kidneys (N =
3—5). Monocyte chemoattractant protein (MCP-1) was increased in both
groups after 2 weeks to 3 times control levels. However, after 4 weeks
MCP-1 expression decreased in rats on 6% protein (1.5 times control) and
reached control levels after 7 weeks. In contrast, in the 24% group it
increased further after 4 weeks (5.6 times control) and was still twofold
higher after 7 weeks. Transforming growth factor-f3 (TGF-/3) was found to
be modestly upregulated in both groups at 2, 4 and 7 weeks to between 120
and 160%. IL-i j3 and TNF-a were not detected. Conclusion: In this model
an initial "mechanical" injury results in a sustained inflammatory response
within the kidney. MCP-i and TGF-j3 may play a role in the pathogenesis
of FGS in this model. A low protein diet modulates the expression of
MCP-1 and improves the morphological outcome after renal ablation,
suggesting an alternative mechanism to the "hyperfiltration" hypothesis.
Evidence for pre-eclampsia in a baboon pregnancy with twins. A.
Hennessy, A.G. Gillin, D.M. Painter, P.J. Ki,win, and J.S. Horvath, Depart-
ments of Renal Medicine and Anatomical Pathology, Royal Prince Alfred
Hospital Camperdown, 2050. Preeclampsia (PE) is a syndrome of hyper-
tension, oedema and proteinuria in pregnancy accompanied by hepatic
damage if severe, which resolves after delivery. A pathognomonic renal
lesion characterised by endothelial swelling, mesangial expansion, double
contouring of the basement membrane and fibrin deposits has been
described. This condition is almost exclusively a human disease and risk
factors for its development include molar pregnancy, multiple pregnancy
and primiparity. Primates rarely develop PE spontaneously. This paper
describes the renal biopsy findings in a case of twinning in a baboon (Papio
hamad,yas) that had an otherwise symptomatically normal pregnancy. The
aim of this study was to demonstrate the similarity of pathological changes
in primate PE with those seen in human pregnancy. Methods. The animal
had a twin pregnancy, duration 180 days (RR 182 5 days), At 173 days
an open wedge renal biopsy was performed and then repeated at five
months post-partum (PP). This animal was studied as part of a wider study
to examine the effect of uteroplacental ischaemia on renal morphology.
Morphometry of the glomerular volume (light microscopy), basement
membrane thickness (BMT) and mesangium volume (MV) on electron-
microscopy (EM) were taken according to methods described previously.
Results. The animal (anaesthetised) had a mean arterial pressure (MAP)
of 104 mm Hg (RR 82 7 mm Hg) at term and PP 88 mm Hg. There was
a 200 fold increase in urinary protein excretion from 0.0014 mmol/gCr
excreted at 139 days to 0.288 mmol/gCr excreted at term, with a decrease
PP to 0.026. There was a decrease in platelet count from 365 X i0/l at 139
days to 245 x 10/l at term. PP the platelet count was 455 X i09/l. There
was no other clinical or biochemical evidence of PE. The term biopsy
demonstrated the presence of deposits, mesangial expansion and diffuse
double-contouring. There were arterial as well as glomerular deposits seen
on LM. These changes had resolved on the PP biopsy. A mild interstitial
nephritis at the time of the term biopsy resolved. On EM there were fibrin
deposits in the term biopsy which had resolved PP. Morphometiy showed
that MV and BMT were measurably decreased on the PP biopsy.
Conclusions. Twinning in primates can be associated with renal morpho-
logical changes that resemble the changes seen in baboons with uteropla-
cental ischaemia and in humans with PE. The baboon remains a suitable
and available model for studying the pathogenesis of preeclampsia.
ANA, anti-cardiolipin and anti-glomerular basement membrane anti-
bodies in ANCA-associated diseases. Judy Savige, Linus Chant Russell
Buchanan, D. Wilson, and D. Davies, University Department of Medicine,
Austin Hospital, Box Hill Hospital, VIC and South Western Pathology
Service, Liverpool, NSW. A number of autoantibodies have been described
in the ANCA-associated diseases. We have looked at the incidence of
ANA, anti-cardiolipin (ACL) and anti-glomerular basement membrane
(GBM) antibodies in serum from patients with Wegener's granulomatosis
(WG), microscopic polyarteritis (MPA), segmental necrotising glomeru-
lonephritis (SNGN) and ANCA-associated vasculitides (VASC).
ANCA ANA ACL anti-GBM
WG 30/36 7/36 10/25 2/25
MPA 30/34 16/34 8/14 1/14
SNGN 8/11 6/il — —
VASC 18/18 8/18 6/14 0/14
ANA were speckled (N = 23), homogeneous (N = 10) or nucleolar (N =
4). There was no correlation between titres of ANCA and ANA, and one
antibody could disappear before the other. ANA were found more often
in MPA than in WG and were associated significantly more often with
pANCA than with cANCA (P < 0.05). Anti-cardiolipin antibodies were
also common in the ANCA-associated vasculitides but there was no
significant association with any disease type. Finally, anti-GBM antibodies
occur in these diseases but are uncommon.
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Detection of glucose-6-phosphate (G-6-P) derived advanced glycosyla-
tion end products in diabetic nephropathy. B.G. Mc William, B.M. ROger,
T.J. Neale, and R.P. Murray-McIntosh, Department of Medicine, Wellington
School of Medicine, P.O. Box 7343, Wellington, N.Z. Proteins may be
nonenzymatically glycosylated eventually forming cross-linked, stable mol-
ecules termed "advanced glycosylation end products" (AGEp5) which
occur in humans with normal aging and at an accelerated rate in diabetes.
Their accumulation is thought to be a biochemical link between chronic
hyperglycaemia and the pathophysiological complications of diabetes,
such as diabetic nephropathy. Glucose is the major circulating sugar and
glucose-derived AGEps have been shown to accumulate in subjects with
diabetes and/or renal impairment. We have detected abundant deposition
of G-6-P derived AGEps immunohistochemically in renal biopsies exhib-
iting diabetic nephropathy and are therefore seeking to determine the
involvement of these compounds in the disease. A competitive ELISA was
developed specifically to detect these products utilising antibody against in
vitro prepared G-6-P-derived AGE-keyhole limpet haemocyanin. In vitro
prepared, G-6-P derived AGE-bovine serum albumin (AGE-BSA), (1 mM
AGE-BSA = 11.55 A350) was bound as the solid phase at a concentration
of 5 ng/well. Whole blood was collected into heparinized tubes from four
groups of subjects: those with diabetes mellitus with and without renal
impairment (serum creatinine > 112 ,aMol/l), and nondiabetic patients
with and without renal dysfunction. Erythrocytes were haemolysed and
delipidated and insoluble material removed. The resulting haemolysate
was assayed for AGEp content by competitive ELISA and protein content
by the BCA reaction. The average AGE unit/mg protein in the haemoly-
sate of patients who had renal failure was significantly higher (mean =
3.97 2.91, P = 0.0001; and mean = 6.52 9.11, P = 0.0003 for diabetic
and non-diabetic patients respectively) than diabetic patients who did not
have renal impairment (mean = 0.22 0.13,P = 0.7442) compared to the
control group (mean = 0.26 0.16). These data show that glucose-6-
phosphate derived AGEps accumulate in the circulation of subjects with
renal impairment from any cause. Renal deposition of AGEp5 in diabetic
patients may be the result of clearance of the increased amounts of
AGEps formed during hyperglycaemia, or local formation in situ.
Isolation and characterisation of potentially bioactive advanced glyco-
sylation end products (AGEPs) by lactoferrin (Lt) binding. C.M Brimer,
R.P. Mun-ay-Mclntosh, and TJ. Neale, Department of Medicine, Wellington
School of Medicine, P0 Box 7343, Wellington South, New Zealand. Circu-
lating and extracellular matrix proteins have been shown to be nonenzy-
matically glycosylated in vivo and in vitro leading to the formation of
AGEPs as brown and/or fluorescent moieties mainly on lysine residues.
AGEPs have been implicated in the chronic complications of diabetes by
alteration of protein character and in the inflammatory responses which
they elicit. We have raised antiserum to in vitro prepared AGEPs and have
detected, in patients with renal failure, enhanced binding in haemolysates
by ELISA and staining of human diabetic kidney by immunohistochem-
istry. However only some of the epitopes present in the immunogen may
be important in stimulating inflammatory or other responses in cells. The
specific cell receptor which binds AGEPs contains a protein with N-
terminal sequence identical to that of Lf, and antibody to Lf binds to this
Lf-like binding protein. Further, AGEP-albumin binds to immobilised Lf.
We have utilised this property of Lf to develop a competitive binding assay
for those AGEPs that bind to Lf. A model AGEP, n-acetyl lysine methyl
ester (ALME) incubated with glucose-6-phosphate (G6P), competes for
Lf in this assay. Competition increased with time of sugar incubation,
corresponding with increased brown and fluorescent character, and was
greater than with ALME incubated with glucose:
AGEP-Bovine Serum Albumin Equiva
Mean (1 SD)
lents (j.Lg/mI)
3 weeks 6 weeks 9 weeks 12 weeks
ALME+glucose 27.1 (4.7) 46.2 (5.1) 48.4 (5.2) 68.0 (6.1)
ALME+G6P 368.5 (34.9) 703.1 (59.5) 1115.9 (100.8) 1536.4 (153.6)
When separated on Biogel PlO, high MW brown fractions (10 kD — >20
kD) competed for Lf, with no binding of lower MW fluorescent fractions.
A Lf affinity column isolated and allowed further characterisation of
potentially bioactive AGEPs from in vitro prepared mixtures. Activity of
the column was confirmed by the binding of albumin incubated with G6P
but not of control albumin. ALME incubated with G6P was applied and
the bound fraction exhibited "brown" character. These Lf-binding AGEPs
will be tested for bioactivity, used to study the nature of cellular responses,
and to isolate antibodies with specificity for bioactive AGEP moieties in
diabetic kidney and other tissues.
The humoral immune response in the lpr mouse. KG.C. Smith, D.M.
Tarlinton, and G.J. V Nossal, Walter and Eliza Hall Institute of Medical
Research, Post Office Royal Melbourne Hospital, Victoria, 3050. The lpr
mouse has a mutation in the fas gene and spontaneously develops an
autoimmune disease similar to SLE. Fas is a cell surface molecule which
can mediate apoptosis. It is expressed on activated T and B lymphocytes
and in germinal centres. An intrinsic B cell defect explains part of the lpr
phenotype. These findings suggest a role for fas in the humoral response
to antigen. We investigated this by comparing the response to the hapten
NP in wild type and lpr C57B1/6 mice. Changes in splenic cellularity after
immunisation were similar in both groups. Total anti-NP 1gM and IgG1
and high affinity anti-NP IgG1 rose to the same levels in both groups.
NP-specific memory B cells were enumerated using 6 parameter FACS
analysis at day 49 after immunisation and the findings confirmed by clonal
culture of splenocytes. They made up 0.01% of splenocytes in both groups
of mice. Finally somatic hypermutation was studied by sequencing V
genes of NP specific cells. In summary splenic involution, affinity matura-
tion of antibody and memory cell generation are all essentially unaffected
by the absence of fas. Thus if fas-mediated apoptosis does play a role in
humoral responses to antigen it is not critical and other mechanisms can
compensate for its absence.
Polyarteritis overlap syndrome: A report of 7 cases. G.S. Kirkland, J.
Savige, P.J. Miach, W. Heale, R.N Hope, and Roger Sinclair, Renal and
Medical Units, University Departments of Medicine and Pathology, Austin
Hospital, Heidelberg, Victoria, Australia 3084. The diagnosis of Polyarteritis
overlap syndrome with features of both microscopic polyarteritis (mPAN)
and classical polyarteritis nodosa (medium vessel arteritis, cPAN) was
made in 7 individuals. mPAN was demonstrated by renal biopsy (N = 6)
or by heavy glomerular haematuria (1); cPAN was demonstrated by renal
biopsy (N = 3) or histological examination of the small bowel (4). There
were 5 males and 2 females with a median age of 61 years (range 60 to 77).
Major clinical features were fever (N = 6), night sweats (5), gastrointes-
tinal bleeding (4), proximal myopathy (3) and peripheral neuropathy (3).
The serum creatinine at presentation ranged from 0.166 to 0.811 mmol/l.
Investigations demonstrated a raised ESR (6), anaemia (6), thrombocy-
tosis (6), hypoalbuminemia (6) and abnormal liver function tests (6). Five
out of 5 individuals tested were positive for ANCA (2 cANCA, 2 pANCA
and 1 not described). One patient died at admission from gastro-intestinal
blood loss but the other 6 were treated with pulse and oral prednisolone,
and cyclophosphamide. All 6 remain alive at follow-up after a median of
33 months (range 3 months to 8 years), and all but one have a serum
creatinine below 0.2 mmol/l (range 0.106 to 0.209). Polyarteritis overlap
syndrome is a not uncommon condition.
Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase anti-
bodies in ANCA-associated diseases. Linus Chang and Judy Savige,
University Department of Medicine, Austin Hospital, Heidelberg, Victoria.
The protein targets of antibodies may be either linear sequences of amino
acids or conformational arrangements. Where the target is a linear
sequence, this peptide could be used in a diagnostic assay; in addition any
homology with bacterial or viral proteins would suggest that these agents
might be important pathogenetically. The aims of this project were to
determine whether anti-proteinase 3 and anti-myeloperoxidase antibodies
recognise linear epitopes. We have used 3 techniques to look for linear
epitopes: polyacrylamide gel electrophoresis (PAGE) under denaturing
conditions, enzymatic digestion followed by separation on PAGE or by
column chromatography, and an ELISA detection system using overlap-
ping peptides (PIN method). We have shown that anti-proteinase 3 and
anti-myeloperoxidase antibodies bind to the corresponding denatured
reduced proteins in SDS in Western blots. However these antibodies do
not appear to bind to small sequences after digestion with lysC. The
antibodies do bind consistently to linear peptide sequences of the corre-
sponding target protein but we have been unable to show that this binding
is specific and the binding may reflect some properties of the peptides
themselves. We conclude that linear epitopes are uncommon in the major
targets of ANCA, proteinase 3 and myeloperoxidase.
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Infiltration of the kidney by wf and 'y T-cells: Effect on progression in
IgA nephropathy. MC. Fal/', G. Ng, G.Y. Zhang, G,C. Fanning, L.P. Roy,
KM. Bannister, A. C. Thomas, A.R. Clarkson, A.i Woodroffe, and IF.
Knight, Renal Research Laboratories, The Children's Hospital, Camperdown
NSWand Renal Unit, RoyalAdelaide Hospital, Adelaide, SA, Australia. The
prognosis of IgA nephropathy (IgAN) is variable and difficult to predict.
Previous studies have shown a link between lymphocytic infiltration in the
interstitium and deterioration in renal function. We sought to confirm this
finding and to further characterise the nature of the T-cells infiltrating the
interstitium, based on the subtypes of T-cell antigen receptors (TCR),
whether the abundant a TCR or the rarer non MHC linked yb TCR,
using reverse transcription (RT) PCR and immunohistochemistry. Thirty-
six archival biopsies were obtained from the Royal Adelaide collection: 12
in each group of (a) non immunological renal disease (controls), (b)
histologically proven IgAN with stable renal function for at least 12
months and (c) IgAN and progressive deterioration in renal function over
at least 12 months. The biopsies had been snap frozen and stored at —70°C
for up to 11 years. RNA was extracted, RT to cDNA and amplified using
PCR with primers specific for p-actin, the constant gene segment of the
alpha (Ca) and delta (Cb) chains. The PCR products were dot blotted
onto a nylon membrane and selectively probed with specific 32P labelled
probes. All specimens were studied in duplicate and the signal was
quantified by two-dimensional densitometry. Results were expressed in
arbitrary units as the ratio of TCR to 13-actin signal for each biopsy.
Biopsies with a poor densitometry score for 13-actin were not included.
Means were compared using the two sample T test. Where sufficient
material was available, biopsies were also studied with monoclonal
antibodies for CD3, TCRI3 and TCR8 using peroxidase staining. Cellular
infiltration was scored by a blinded observer on a four-point scale. Results








n CD3 TCRI3 TCRb
Progressive 7 41.84 28.60 9 2.89 2.67 0.78
Stable 7 19.12 6.27 7 1.29 1.14 0.17
Control 7 5,81 4.55 6 1.17 0.50 0.0
On RT-PCR significant differences were seen between controls and
IgAN-progressive for Ca (P < 0.01) and for Cb (P < 0.01). On
immunohistology significant differences were seen for both types of T-cell
between controls and IgAN-progressive (CD3 P < 0.01, TCRI3 P < 0.001,
TCR P < 0.01) and also between IgAN-stable and IgAN-progressive(CD3 P < 0.01, TCR/3 P < 0.01, TCRb P < 0.05). This study confirms the
relationship between lymphocytic infiltrate and deterioration in renal
function for patients with IgAN. a13 T-cells were increased in both stable
and progressive disease. Significant numbers of yb T-cells are only seen in
biopsies of progressive IgAN. This new observation has prognostic and
therapeutic implications.
Alteration in T lymphocyte function in children with nephrotic syn-
drome. Stephen Alexander, Kevin Forsyth, and Ian K Hewitt, Renal and
Immunology Units, Princess Margaret Hospita4 Perth, Western Australia. To
investigate the differences in lymphocyte response to immunosuppression
in nephrotic syndrome, we studied suppression of lymphocyte prolifera-
tion in children with nephrotic syndrome. Ten patients were studied, 6 in
remission off steroids, 3 who were steroid resistant and had required
cyclophosphamide and 1 in relapse. There were 6 boys and 4 girls (ages 22
months—14 years 10 months). There were 10 controls in hospital for minor
surgery. Five were boys and 5 girls (ages 27 months—13 years 5 months).
Ten mis of blood was separated using ficoll-hypaque then washed with
RPM! counted and suspended in RPM! with 10% FCS and 1% pyruvate,
glutamine and non essential amino-acids. io cells were suspended in each
well of a 96 well tray. Lymphocytes were cocultured with either PHA or
anti-CD3 as mitogens and then either prednisolone or cyclosporin A were
added in varying concentrations. The lymphocytes were incubated for 48
hours and pulsed for 18 hours with tritiated thymidine. Cells were
harvested on a titretrek analysed on a scintilator and results expressed as
a proportion of maximal response. Lymphocytes were also analysed using
flow cytometry to study a range of subclass and activation markers. The
lymphocytes showed a trend of delayed suppression in those stimulated by
PHA but not in those stimulated by anti-CD3. There were no significant
differences in the cell surface markers examined by flow cytometry.
Detection of mutations in Alport's syndrome. C. Pham, Judy Savige, I
Agar, P. Miach, J. Dawborn, W. Heale, D. Wilson, and G. Thomas, University
Department of Medicine and Renal Unit, Austin Hospital, Renal Unit
Geelong Hospital and Department of Medicine, Box Hill Hospita4 Victoria.
In most patients, the inheritance of Alport's syndrome is X-linked and in
about 10% of these a mutation has been demonstrated in the alpha 5 chain
of type IV collagen. We report here our results in a study of 9 affected
families. DNA was extracted from peripheral blood leucocytes, cut with
the restriction enzymes EcoRI, PstI and TaqI, electrophoresed, blotted
and probed. The eDNA probes were derived from polymerase chain
reaction (PCR) amplification of normal human mRNA using primers
from the published sequence of the alpha 5 chain of type IV collagen. No
novel alleles were demonstrated indicating that there were no large
deletions nor sequence substitutions that altered the restriction enzyme
recognition sites in any of these families. We suspected that autosomal
recessive inheritance was implicated in one of these families and examined
the DNA with eDNA probes from the alpha 3 and 4 chains of type IV
collagen. Again however we found no mutations. We conclude that the
majority of mutations in Alport's syndrome are single base pair substitu-
tions, and some may affect a novel type IV collagen chain and non-coding
regions of the gene. Finally we have shown that mRNA corresponding to
the alpha 5 chain is present in both skin and bone marrow and these
tissues can be used to look for single base pair substitutions using PCR and
direct sequencing.
Assessment of adequate dialysis delivery in continuous ambulatory
peritoneal dialysis (CAPO). L.H. Fung, C.A. Pollock, L.S. Ibels, Ri.
Caterson, D.A. Waugh, C. Macadam, and IF. Mahony, Department of Renal
Medicine, Royal North Shore Hospital, St Leonards, 2065, Australia. Al-
though adequate dialysis and its parameters are reasonably well estab-
lished in conventional haemodialysis, its assessment in CAPD is as yet ill
defined. The present study was designed to assess the relevance of urea
kinetic modelling and the peritoneal equilibration test (PET) in CAPD in
relation to nutritional markers and overall morbidity. Twenty-four hours
dialysate and urine collections were made in 25 patients (13 M, 12 F; age
21—77 years) on CAPD for 15.2 2.9 months, from which the Kt/V,
protein catabolic rate (PCR), urea and creatinine clearances were deter-
mined. The following day patients underwent a standard four hours PET
at which time serum albumin, cholesterol, triglycerides and total protein
were also measured. Data regarding total body nitrogen (TBN) measure-
ment within the preceding 6 months, hospital admissions and infectious
complications within the last 12 months were reviewed. The study
demonstrated that total KtIV delivered was highly dependent on residual
renal function (P < 0.0001), and KtIV derived from peritoneal clearance
diminished with increasing age (P < 0.01). However, a higher delivered
total Kt/V was associated with increased PCR (P < 0.05), which in turn
was associated with an improved TBN (P < 0.05). The TBN further
correlated with peritoneal glucose absorption (P < 0.005). Hospital
admission rate decreased with improved PCR, although it failed to reach
statistical significance (P = 0.067). Infectious complications further cor-
related with time on dialysis (P < 0.005) and with dialysis protein loss (P
< 0.05), but not with serum albumin (P = 0.31). Although KtIV
determinations did not correlate with clearances determined by the PET,
the dialysate/plasma creatinine ratio (DIP Cr) did correlate with PCR (P
<0.05) and with TBN (P < 0.001) but not with infectious complications
nor hospitalization. The D/P Cr further correlated with peritoneal glucose
absorption (P < 0.0005) and inversely correlated with ultra-filtration rate(P < 0.05). In general, serum albumin did not correlate with morbidity,
nor other markers of dialysis adequacy. However, in female patients the
rate of hospital admissions decreased with improved albumin level (P <
0.05). In conclusion, nutritional parameters of TBN and PCR correlate
with outcome on CAPD. An integral relationship exists between nutri-
tional status and dialysis delivery, which is best assessed by urea kinetic
modelling. Although D/P Cr is a reasonable marker of nutritional status in
CAPD patients, its value in assessing the adequacy of dialysis delivery is
yet to be determined.
Total body nitrogen (TBN) as a prognostic marker in maintenance
dialysis. CA. Pollock, L.S. Ibels, B.J. Allen, W. Ayass, R.J. Caterson, D.A.
Waugh, C. Macadam, Y. Pennock, and J,F. Mahony, Department of Renal
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Medicine, Royal North Shore Hospital, NSW 2065. It is increasingly
appreciated that adequate dialysis is reflected in an adequate nutritional
state and both are necessary to achieve an ultimately good prognosis. In
order to assess long term nutritional adequacy, 151 patients (77 M, 74 F),
aged 55.3 1.3 yrs on maintenance dialysis (73 HD, 78 CAPD),
underwent measurement of TBN by neutron activation analysis. Dietary
history, anthropometrics and serum albumin were also measured. Sixty-
eight patients were reassessed 22.6 2.1 (6—72) months later. In cross
sectional analyses anthropometric measurements and dietary intake re-
mained stable over time in all patients. However, a significant fall in TBN
occurred in the HD population with increasing time on dialysis (P < 0.05).
In the prospective analyses, the fall in TBN in HD patients (N 36),
expressed as a % of normal nitrogen in the matched population (Nitrogen
Index), did not reach significance (87.6 0.2 vs. 85.3 1.8%; P = 0.16),
but in the CAPD patients (N = 25) a significant increase in TBN occurred
(89.2 3.3 vs. 95.2 3.1%; P <0.05). tn 7 patients who transferred from
CAPD to HD a fall in TBN was evident 96.6 7.2 vs. 85.3 2.2%; P <
0.05). TBN correlated with total caloric intake estimated from the dietary
history (P < 0.05), but not with estimated protein intake. During follow up
38 patients died. These patients were older (P < 0.05). In the APD
population they had been on dialysis for a greater length of time (34.3
5.3 vs. 15.5 2.6 months; P < 0.05), although this was not the case in the
HD patients. In all dialysis patients, those who died had a lower TBN
expressed both as g/kg lean body mass (31.0 0.6 vs. 33.5 0.4; P <
0.005) and as the nitrogen index (87.2 2.1 vs. 92.8 1.4%; P < 0.05).
A lower serum albumin was associated with mortality in the APD
patients (35.8 0.6 vs. 31.6 3.8 g/dl; P < 0.05), but this relationship was
not observed in the FID subpopulation. Anthropometric measurements
and dietary history were similar in those who died compared with
survivors. We conclude that CAPD exerts a favourable influence on TBN
and that anabolism is possible. No such effect was observed in the HD
patients. In both populations TBN is inversely associated with increased
mortality which is not predictable from measurements of anthropometry
or serum albumin. Total caloric intake determined by dietary history is a
better index of nutritional adequacy than is estimated protein intake.
Accuracy, patient tolerance and time-efliciency of volumetric versus
manual ultrafiltration (UF) on haemodialysis (HD). D. Perreit, S. Porter,
F.S.D. Ken, A. Parnham, Incentre Dialysis Staff G. Thatcher, P. Hurst, and
M Thomas, Dept. of Nephrology, Royal Perth Hospital, WA 6001. To
determine whether the added cost of volumetric UF devices affects the
accuracy, tolerance or nurse-time efficiency of maintenance HD, a cross-
over comparison with manual UF (via calculated trans-membrane pres-
sure) was performed in 12 patients with recurrent hypotension on Incentre
hospital HD. The mean absolute difference between the desired and
actual post-dialysis body weight, the incidence of hypotension (fall in
systolic BP > 25 mm Hg or need for saline), visual analogue symptom
(VAS) scores (nausea, headache, cramp, itch and well-being) and stop-
watch-recorded nurse UF calculation times were studied for 3 dialyses on
each form of UF on 2 consecutive weeks. All patients used cuprophane
membranes, Cobe Centry 2 HD machines, bicarbonate dialysate, with no
change in dialysis prescription, dialysis nurse or clinical status during the
study period. The sample size was selected to detect a difference in desired
versus actual post-dialysis weight of 0.3 kg between the 2 forms of UF with
90% power at .01 level of significance. Data was expressed either as mean
(Sn) and categorically (improved, unchanged, worsened) and analysed by
one-way ANOVA and Chi-square test. All patients completed the study.
There were no significant differences between volumetric and manual UF
in any parameter either pre-HD (not shown) or post-HD (Table),











Manual 0.2 (0.1) 25 (17) 3.8 (3.0) 297 (106)
Volumetric 0.3 (0,1) 14 (17) 3.8 (3.1)
-
256 (118)
This study shows no justification for the use of volumetric UF in
maintenance HD using cuprophane membranes.
The effect of controlled lipid lowering diet on plasma lipids of dialysis
patients. D. Saltissi, C. Morgan, and B. Knight, Department of Renal
Medicine, Royal Brisbane and Kepeira Hospitals, Brisbane, Queensland.
Dietary manipulation is advocated as primary therapy for dyslipidaemia.
In Uraemia the complex requirements/restrictions make adherence to
NHF lipid lowering dietary guidelines and patient compliance difficult.
Also there is no data to support benefit of such manipulation. We have
conducted a 14 week study of dietary control, in dialysis patients, limiting
total fat intake to 30% (PD) and 40% (HD) of total calories with as close
a 1:1:1 poly:mono:saturated fat ratio as possible. Results:
Mean values: standard errors omitted for brevity
TC Trig HDL LDL VLDL
Weeks 0 14 0 14 0 14 0 14 0 14
HD 5.70 5.65 2.40 2.10 1.02 1.06 3.70 3.60 0.95 0.97
+
32pts P=NS P=NS P=NS P=NS P=NS
PD 6.33 6.13 2.14 2.36 1.19 1.02 4.15 3.41 0.97 0.98
10 pts P = NS P = NS P = 0.0225* P = NSP P = NS
42 pts (12 M, 30 F; age 38—75, mean 59.4 yrs)
* Associated with fall in monounsaturated fat
+ Associated with a fall in total energy
Further data will be presented. Current dialysis diets are close to
optimum. Further manipulation according to NHF lipid lowering recom-
mendations may be deleterious. Treatment of uraemic dyslipidaemia is
likely to require pharmacological therapy.
A new, non-invasive method of measuring blood volume (By) during
haemodialysis using optical techniques. D. W. Johnson, M.P. McMahon,
S.B. Campbell, and S.J. Fleming Department of Renal Medicine, Royal
Brisbane Hospital, Qld, 4029. To aid in the clinical assessment of patient
hydration state, we developed an inexpensive method of measuring BV
during haemodialysis, based on the linear relationship between BV and
haemoglobin concentration ([Hb]) and between Hb] and near-infrared
light absorption by blood. An optical monitor and light source were
clamped across transparent blood lines in 10 haemodialysis patients in
order to provide a continuous recording of [Hb]. In each patient, a strong
linear correlation was found between received optical power and [HbI
concentration (r  0.975). By analysing the rates of change of [I-IbJ, and
therefore of By, at two different rates of fluid removal and solving 2
simultaneous equations, BV was determined in 10 patients and compared
with the concomitant BV measured by the standard technique of radio-
isotope dilution. Using linear regression, a statistically significant, strong
correlation was found between the two methods (P 0.004, r = 0.822, y
= 3.707 + 0.225x). The overall accuracies of the spectrophotometrically-
derived BV measurements were of the order of 400 ml. The advantages
of the technique included its simplicity, low cost, rapidity, repeatability,
safety and portability. In conclusion, we found that this practical new
technique could accurately measure BV during a haemodialysis session,
thus providing a useful adjunct to the clinical assessment of hydration
state.
Calcium acetate (CA) versus calcium carbonate (CC) in haemodialysis
patients. J. Connolly, M. Mantha, and D.C.H. Hariis Department of Renal
Medicine Westnzead Hospita4 NSW 2145. Although available overseas for
several years, CA has only just become available in Australia. To test a
new Australian formulation CA was compared to CC in a 24 week
randomised, blinded, cross-over study in 31 maintenance haemodialysis
(lID) patients, aged 51 24 (an) yrs. Data up until the time of crossover
(12 weeks) are available. During and following an initial run-in period of
4 weeks 14 patients received CA first, and 17 patients CC. Mylanta was
added when serum phosphate was > 1.80 mmol/L with maximum toler-
ated dose of CA or CC. Prior to crossover, serum calcium was 2.37 0.15
(CA) and 2.46 0.21 (CC) mmol/L, P = NS. Serum phosphate was 1.36
0.21 (CA) and 1.52 0.21 (CC) mmol/L, P = NS. There were 2
episodes of hypercalcaemia ( 2.70 mmol/L) in 1 patient with CA, and
5 episodes in 2 with CC. Serum phosphate was  2.00 mmol/L on 2
occasions in 2 patients on CA, and on 5 occasions in 2 on CC. CA dose at
crossover was 2000 912 mg Ca2 day, and CC dose 2356 2072 mg
Ca2/day. Although mean Mylanta dose was similar in the both groups
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(1000 mgs/day, 6 patients on CC required Mylanta, whereas only 2 on CA
did). There were 5 dropouts during CA (due to renal transplant in 1,
severe itching in 2, diarrhoea in 1, and 1 non compliance) and 5 during CC
(2 died of unrelated cause, 3 non compliance). Preliminaiy results of this
trial suggest that this formulation of CA is a satisfactory alternative to CC
in HD. Compliance with CA may be improved by increasing tablet
strength.
Tumour necrosis factor alpha (TNF-a) in human membranous ne-
phropathy (MN): A role for glomerular epithelial cells (GEC). TJ. Neale,
H. Macaulay, B.M Ruger, A. Bourke, R. Dunbar, and Q. Hasan, Dept. of
Medicine, Wellington School of Medicine. TNF-a, a pleiotropic and pro-
inflammatory cytokine has been implicated in the pathogenesis of exper-
imental glomerular disease. We examined its role in biopsy-proven human
GN by monoclonal antibody immunohistochemistry on paraffin-embed-
ded tissue (N = 78), digoxigenin-labelled oligonucleotide anti-sense probe
in situ hybridisation, immunogold electron microscopy, quantitative im-
munoassay (ELISA and IRMA) (N = 64) and urinary immunoblot.
Striking glomerular capillary wall and GEC staining was observed in all
cases of MN (N = 13) and in membranous lupus nephropathy (N = 3 of
12). By immunogold EM TNF-a was localised to the GBM in MN
especially in relation to immune deposits and within the GEC. Minimal
change, FGS and IgA nephropathy sections showed no GEC or GBM
TNF-a staining. In situ hybridisation localised TNF-a mRNA exclusively
to GEC in all biopsies with membranous morphology but not in other
histologic sub types. [TNF-a] was increased above normal in the serum
and urine of patients with a variety of forms of GN but with statistical
significance only in the urine of patients with MN (mean 23.2 12 pg/mI,
range 10—56, versus controls (N = 20): mean 5,32 3.7, range 0—14 pg/ml;
P < 0.05). Immunoblot of urine revealed monomer or trimer TNF-o in all
patients with MN. Auto antibodies against TNF-a were detected in 14/64
GN patients; 9/14 were associated with elevated urinary [TNF-a]. The
upregulation of TNF-a mRNA and expression of the protein in MN GEC
and GBM further supports the contention that the GEC are targets for
injury in MN. TNF-a may contribute from this source to glomerular
capillary wall injury in MN resulting in proteinuria.
Epidermal growth factor (EGF) in remnant kidney model of glomeru-
loscierosis (GS): Effect of enalapril treatment. A.M Walker, and N.M
Thomson, Dept. Medicine, Monash Medical School, Alfred Hospita4 Prah-
ran, Melbourne, 3181, Australia. We have recently reported alterations in
EGF and its mRNA expression in rats developing GS following 7/8
nephrectomy. Enalapril has been demonstrated to inhibit compensatory
renal growth (CRG) and slow the development of renal failure and
glomeruloscierosis in rat remnant kidney model of chronic nonimmune
injury. We have therefore studies the effect of enalapril on EGF and EGF
mRNA expression in this model of GS. Twelve week old, male inbred SD
underwent either 7/8 nephrectomy by infarction or sham laparotomy (Sh).
Rats were randomly assigned to receive enalapril in drinking water (ENx)
or water alone (Nx) and progression of renal failure followed. Animals
were killed at regular intervals over a 12 week period and tissue assessed
for histological damage. Tissue expression of EGF was determined by
immunoperoxidase using rabbit anti-mouse EGF polyclonal antibody and
EGF mRNA was quantitated by Northern blot analysis. When assessed at
12 weeks, enalapril had prevented the compensatory increase in renal
weight (1.13 0.12 g ENx, 1.88 0.18 g Nx, 1.26 0.06 g Sh), had
reduced the rate of loss of renal function (s Cr 120 18 mmol/l ENx, sCr
163 8 Nx at 12w) and had minimised proteinuria (95 30 mg/day ENx,
241 102 mg/day Nx at 12 w). Glomerular hypertrophy developed more
slowly with enalapril treatment and glomerulosclerosis (GS) evident in
only 6% glomeruli compared with 40% glom. in Nx group at 12 w.
Preservation of tubulointerstium was observed in the treatment group.
Epidermal growth factor protein was expressed in the distal convoluted
tubules of all kidneys collected before the 3rd postoperative week in the
Nx animals but had disappeared by the 6th week. Enalapril treatment
(ENx) preserved the EGF expression at all time points examined. mRNA
expression was increased at week 1, then progressively fell to levels
comparable to sham by the 6th week. There was a subsequent increase in
mRNA expression at later time points in the untreated animals. Thus
there was a discrepancy between EGF expression and expression of EGF
mRNA in animals developing GS. Whether this represents inhibition of
EGF production or loss of the protein remains unresolved.
Clearance of a bacterial challenge to the peritoneal cavity in subjects
undergoing peritoneal dialysis. T.E. Miller and G. Findon, Department of
Medicine, University of Auckland, Auck.an4 NZ. Dialysis, and the associ-
ated dilution of host defenses in the peritoneal cavity, is thought to be an
important factor contributing to peritonitis in CAPD. We have used an
animal model of CAPD to explore the effect of dialysis on the clearance
of several pathogens commonly introduced into the peritoneal cavity at
the time of bag exchange. The experiments have shown that the ability of
the host defense mechanisms to clear a bolus challenge remains largely
intact despite considerable, dialysis associated changes to the peritoneal
milieu. Substantial challenges of up to 108 viable microorganisms were
either cleared from the peritoneal cavity or reduced to small but persistent
numbers in the case of £ aureus, S. epidermidis and Candida albicans. Ps.
aeruginosa on the other hand became established in the peritoneal cavity
in large numbers after an initial reduction. Challenges with S. aureus and
Ps. aeruginosa led to adhesion formation which encased the cannula and
prevented dialysis. Clearance of viable organisms in the presence of







S. epidennidis ++++ +++ —
S. aureus ++++ + +
Ps. aeruginosa + + — +
C. albicans ++ ++++ —
We conclude that contrary to expectations, host defences in the peritoneal
cavity appear intact in dialysed subjects challenged with pathogens com-
monly causing peritonitis in humans. Furthermore, adhesion and cannula
blockage appear to be a microbial rather than host determinant.
Tissue factor pathway inhibitor is produced by rabbit renal cortical
tissue. J. Apostolopoulos, J.H. Erlich, SR. Holdsworth, and P.G. Tipping,
Department of Medicine, Monash University, Clayton, Vic 3168. Tissue
factor (TF) is the most important initiator of coagulation in inflammatory
tissue injury. Glomerular expression of TF is markedly upregulated in
forms of glomerulonephritis with prominent fibrin deposition. Tissue
factor pathway inhibitor (TFPI), recently cloned for human and rabbit, is
the major inhibitor of TF. TFPI is made predominantly by endothelial
cells and has been shown to be upregulated by inflammatory cytokines (eg
IL-i and TNF-a) in vitro. However, its expression in renal tissue and its
participation in glomerulonephritis (GN) has not been described. The aim
of the current study was to a) determine whether TFPI is expressed in
normal renal tissue b) to assess whether TFPI is regulated by proinflam-
matory signals and c) determine whether TFPI mRNA expression is
altered during anti-GBM GN. Northern blot analysis using a eDNA probe
to rabbit TFPI (a generous gift of Dr. James Wun) that hybridises to the
two known TFPI mRNA species (4.0 and 1.4 Kb) was used to assess TFPI
mRNA levels in a) normal rabbit cortex b) rabbits injected with LPS and
c) rabbits up to 4 days post-induction of anti-GBM antibody initiated
crescentic ON. TFPI mRNA was detectable in normal rabbit kidney cortex
and TFPI mRNA and was upregulated in LPS treated rabbits. On day 1 of
anti-GBM disease, glomerular inflammation was associated with macro-
phage influx, fibrin deposition and down-regulation of TFPI mRNA. TFPI
mRNA levels returned to normal by day 4. This study thus demonstrates
that TFPI is expressed in renal cortex and is rapidly down-regulated in
crescentic anti-GBM GN with fibrin deposition.
T lymphocyte initiated glomerulonephritis requires P selectin interac.
tion.XR. Huan P.G. Tipping, MC. Bemdt, and S.R. Holdswortk Monash
University Dept. of Medicine, Monash Medical Centre, Clayton 3168 and
Baker Medical Research Institute, Prahran. Immediate injury in autologous
phase anti-GBM antibody initiated GN has many features characteristic of
delayed type hypersensitivity (DTH). Sensitized rats rechallenged with
sheep globulin 5 days later (in the skin by subcutaneous injection and in
the glomerulus by iv. injection of sheep anti rat GBM globulin) develop
delop a local T cell dependent macrophage influx and injury characteristic
of DTH. The requirement for endothelial P selectin in T cell and
macrophage localization was assessed by the administration of rabbit anti
P Selectin antibody one hour before antigen rechallenge. Control rats
given normal rabbit globulin developed immediate proteinuria (42.1 ±
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14.1 mg/24 hrs mean SD normal 6.3 3.2 mg/24 hr) together with T cell
(1.0 0.06 cells/glom cross section c/gcs; normal 0.1 0.02 c/gcs) and
macrophage (4.2 0.26 c/gcs; normal 0.1 0.1 c/gcs) infiltration. Dermal
rechallenge results in skin swelling (sheep globulin response 3.1 0.7 mm;
horse globulin response 3.1 0.7 mm (P < 0.05). Rats given anti-P
selectin antibody had significantly less proteinuria (13.8 7.3 mg/24 hrs)
as well as glomerular T cell (0.3 0.06 c/gcs) and macrophage influx (0.7
0.13 c/gcs) all P < 0.05. Dermal skin response to sheep globulin
rechallenge was significantly reduced to control levels (1.8 0.1 mm P <
0.05). These results suggest that the primary effector response in dermal
and glomerular DTH is P selectin dependent T cell recruitment.
Clusterin expression in experimental cyclosporine A (CyA) nephrotox-
icity. T. Hewitson, IA. Darby, C. Jones, M. Fraenkel, and G. Becker, Howard
Florey Institute of Experimental Physiology and Medicine, University of
Melbourne and Department of Nephrology, Royal Melbourne Hospital,
Victoria 3050 Australia. Objective: Clusterin (rat sulphated glycoprotein-2)
has been isolated from several tissues including the kidney and is thought
943
to be induced during tissue damage. We have examined the expression of
the clusterin gene in the kidney during the development of cyclosporine A
(CyA) induced nephrotoxicity in the rat using in situ hybridization
histochemistiy. Design and Methods: Female Sprague Dawley rats (170 g)
were divided into experimental or control groups and were given intra-
peritoneal injections of CyA (25 mg/kg) or vehicle respectively for 2, 4, and
6 weeks. Kidneys from animals sacrificed at these times were fixed in 4%
paraformaldehyde and embedded in paraffin. Tissue sections were hybrid-
ized using either a sense or antisense riboprobe of 1100 bases comple-
mentary to clusterin mRNA which was labelled with P32. Results: Clusterin
gene expression was not detected in control animals. Expression of
clusterin in distal convoluted tubules of CyA treated animals was evident
at 2 weeks and increased substantially at 4 weeks and 6 weeks. The
increase in clusterin positive tubules was associated with progression of
tubulointerstitial nephritis. At 6 weeks clusterin expression was also seen
in afferent arterioles, the glomerular capsule and transitional epithelium
of the renal pelvis of CyA treated rat kidneys. No specific labelling was
seen at any time with the sense probe. Conclusions: CyA nephrotoxicity is
associated with a progressive increase in clusterin gene expression in
tubules and arterioles, which precedes histopathological lesions and may
be a marker of cell injury.
